DK0733059T3 - Forbindelser og fremgangsmåder til site-rettede mutationer i eukaryote celler - Google Patents

Forbindelser og fremgangsmåder til site-rettede mutationer i eukaryote celler

Info

Publication number
DK0733059T3
DK0733059T3 DK95905337T DK95905337T DK0733059T3 DK 0733059 T3 DK0733059 T3 DK 0733059T3 DK 95905337 T DK95905337 T DK 95905337T DK 95905337 T DK95905337 T DK 95905337T DK 0733059 T3 DK0733059 T3 DK 0733059T3
Authority
DK
Denmark
Prior art keywords
polynucleotide
site
compounds
methods
eukaryotic cells
Prior art date
Application number
DK95905337T
Other languages
Danish (da)
English (en)
Inventor
Eric B Kmiec
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Application granted granted Critical
Publication of DK0733059T3 publication Critical patent/DK0733059T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Environmental Sciences (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95905337T 1993-12-09 1994-12-09 Forbindelser og fremgangsmåder til site-rettede mutationer i eukaryote celler DK0733059T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16430393A 1993-12-09 1993-12-09
PCT/US1994/014181 WO1995015972A1 (en) 1993-12-09 1994-12-09 Compounds and methods for site-directed mutations in eukaryotic cells

Publications (1)

Publication Number Publication Date
DK0733059T3 true DK0733059T3 (da) 2000-10-16

Family

ID=22593886

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95905337T DK0733059T3 (da) 1993-12-09 1994-12-09 Forbindelser og fremgangsmåder til site-rettede mutationer i eukaryote celler

Country Status (15)

Country Link
US (3) US5565350A (de)
EP (1) EP0733059B1 (de)
JP (1) JP3585238B2 (de)
KR (1) KR100386337B1 (de)
CN (2) CN1048254C (de)
AT (1) ATE196311T1 (de)
AU (1) AU691550B2 (de)
CA (1) CA2178729A1 (de)
DE (2) DE69425903T2 (de)
DK (1) DK0733059T3 (de)
ES (1) ES2149962T3 (de)
GR (1) GR3034988T3 (de)
NZ (1) NZ278490A (de)
PT (1) PT733059E (de)
WO (1) WO1995015972A1 (de)

Families Citing this family (801)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2268476A1 (en) * 1991-07-03 1998-04-30 Hyal Pharmaceutical Corporation Use of hyaluronan in gene therapy
US6335434B1 (en) 1998-06-16 2002-01-01 Isis Pharmaceuticals, Inc., Nucleosidic and non-nucleosidic folate conjugates
US8153602B1 (en) 1991-11-19 2012-04-10 Isis Pharmaceuticals, Inc. Composition and methods for the pulmonary delivery of nucleic acids
US20020108136A1 (en) * 1997-03-21 2002-08-08 Sri Transgenic animals produced by homologous sequence targeting
US5523389A (en) * 1992-09-29 1996-06-04 Isis Pharmaceuticals, Inc. Inhibitors of human immunodeficiency virus
ATE247128T1 (de) 1993-09-03 2003-08-15 Isis Pharmaceuticals Inc Aminoderivatisierte nukleoside und oligonukleoside
US6420549B1 (en) 1995-06-06 2002-07-16 Isis Pharmaceuticals, Inc. Oligonucleotide analogs having modified dimers
US5760012A (en) * 1996-05-01 1998-06-02 Thomas Jefferson University Methods and compounds for curing diseases caused by mutations
US5731181A (en) * 1996-06-17 1998-03-24 Thomas Jefferson University Chimeric mutational vectors having non-natural nucleotides
US7875733B2 (en) 2003-09-18 2011-01-25 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US20030044941A1 (en) 1996-06-06 2003-03-06 Crooke Stanley T. Human RNase III and compositions and uses thereof
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
AU6659898A (en) * 1997-03-03 1998-09-22 Perkin-Elmer Corporation, The Improved chimeric oligonucleotide vectors
US5948653A (en) * 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
US6524613B1 (en) 1997-04-30 2003-02-25 Regents Of The University Of Minnesota Hepatocellular chimeraplasty
GB9711015D0 (en) * 1997-05-28 1997-07-23 Zeneca Ltd Improvements in or relating to organic compounds
WO1999001579A1 (en) 1997-07-01 1999-01-14 Isis Pharmaceuticals, Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal
US7094606B2 (en) * 1997-08-05 2006-08-22 Arntzen Charles J Use of mixed duplex oligonucleotides to effect localized genetic changes in plants
EP1032692A1 (de) 1997-11-18 2000-09-06 Pioneer Hi-Bred International, Inc. Gezielte manipulierung von herbizid-resistanz-gene in planzen
DK1034262T3 (da) 1997-11-18 2005-11-28 Pioneer Hi Bred Int Sammensætninger og fremgangsmåder til genetisk modifikation af planter
US7102055B1 (en) 1997-11-18 2006-09-05 Pioneer Hi-Bred International, Inc. Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
EP0945507A1 (de) * 1998-03-27 1999-09-29 Boehringer Mannheim Gmbh Tumorspezifische Expressionskontrollregion und deren Verwendung
US20040186071A1 (en) 1998-04-13 2004-09-23 Bennett C. Frank Antisense modulation of CD40 expression
US6004804A (en) 1998-05-12 1999-12-21 Kimeragen, Inc. Non-chimeric mutational vectors
US6010907A (en) * 1998-05-12 2000-01-04 Kimeragen, Inc. Eukaryotic use of non-chimeric mutational vectors
WO1999060012A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
WO1999060167A1 (en) 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
US6693185B2 (en) 1998-07-17 2004-02-17 Bayer Bioscience N.V. Methods and means to modulate programmed cell death in eukaryotic cells
DE19836098A1 (de) 1998-07-31 2000-02-03 Hoechst Schering Agrevo Gmbh Pflanzen, die eine modifizierte Stärke synthetisieren, Verfahren zur Herstellung der Pflanzen, ihre Verwendung sowie die modifizierte Stärke
US6077709A (en) 1998-09-29 2000-06-20 Isis Pharmaceuticals Inc. Antisense modulation of Survivin expression
BR9914465A (pt) 1998-09-29 2001-10-09 Gamida Cell Ltd Métodos para controlar a proliferação e a diferenciação de células-tronco e células progenitoras e uma composição farmacêutica para induzir a diferenciação em uma população de células
EP1131452B1 (de) 1998-11-09 2014-01-22 Bayer CropScience Aktiengesellschaft Nukleinsäuremoleküle kodierend für ein r1 protein aus reis und deren verwendung zur herstellung von veränderter stärke
US6438561B1 (en) * 1998-11-19 2002-08-20 Navigation Technologies Corp. Method and system for using real-time traffic broadcasts with navigation systems
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US20030054390A1 (en) * 1999-01-19 2003-03-20 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
AU2415200A (en) * 1999-01-18 2000-08-01 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
EP1062614A1 (de) 1999-01-19 2000-12-27 Maxygen, Inc. Verfahren zur herstellung von zeichenketten, polynukleotiden und polypeptiden
US20070065838A1 (en) * 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6127124A (en) * 1999-01-20 2000-10-03 Isis Pharmaceuticals, Inc. Fluorescence based nuclease assay
EP2368575B1 (de) * 1999-04-08 2014-10-01 Intercell USA, Inc. Trockenformulierung für transkutane immunisierung
US7098192B2 (en) 1999-04-08 2006-08-29 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of STAT3 expression
DE60040659D1 (de) 1999-05-07 2008-12-11 Du Pont Auxin transportproteine
US6656730B1 (en) 1999-06-15 2003-12-02 Isis Pharmaceuticals, Inc. Oligonucleotides conjugated to protein-binding drugs
US6271360B1 (en) 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
AU7875400A (en) 1999-10-07 2001-05-10 Valigen, Inc. Compositions and methods for plant genetic modification
AR025996A1 (es) 1999-10-07 2002-12-26 Valigen Us Inc Plantas no transgenicas resistentes a los herbicidas.
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US20030190644A1 (en) 1999-10-13 2003-10-09 Andreas Braun Methods for generating databases and databases for identifying polymorphic genetic markers
US7820878B2 (en) * 1999-11-19 2010-10-26 Kyowa Hakko Kirin Co., Ltd. Production of ungulates, preferably bovines that produce human immunoglobulins
WO2001035735A1 (en) * 1999-11-19 2001-05-25 Hematech, Llc Production of ungulates, preferably bovines that produce human immunoglobulins
US7414170B2 (en) * 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
US7074983B2 (en) * 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
US6261840B1 (en) 2000-01-18 2001-07-17 Isis Pharmaceuticals, Inc. Antisense modulation of PTP1B expression
US20020055479A1 (en) 2000-01-18 2002-05-09 Cowsert Lex M. Antisense modulation of PTP1B expression
US20060134629A1 (en) * 2000-03-20 2006-06-22 Link Charles J Methods and compositions for elucidating protein expression profiles in cells
US6897020B2 (en) * 2000-03-20 2005-05-24 Newlink Genetics Inc. Methods and compositions for elucidating relative protein expression levels in cells
US6936467B2 (en) 2000-03-27 2005-08-30 University Of Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
MXPA02009627A (es) * 2000-03-27 2004-05-14 Univ Delaware Modificaciones genomicas cromosomicas selectivas con oligonucleotidos modificados de un solo filamento..
CA2409172A1 (en) * 2000-05-17 2001-11-22 University Of Delaware Plant gene targeting using oligonucleotides
US6686188B2 (en) * 2000-05-26 2004-02-03 Amersham Plc Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
US6656700B2 (en) * 2000-05-26 2003-12-02 Amersham Plc Isoforms of human pregnancy-associated protein-E
US20030017593A1 (en) * 2000-06-05 2003-01-23 Gamper Howard B. Binary hybrid mutational vectors
US7468475B2 (en) 2000-06-16 2008-12-23 Schmuelling Thomas Method for modifying plant morphology, biochemistry and physiology
US6958214B2 (en) 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
AU2001279069A1 (en) * 2000-07-27 2002-02-13 University Of Delaware Methods for enhancing targeted gene alteration using oligonucleotides
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
US20020119570A1 (en) * 2000-09-25 2002-08-29 Kyonggeun Yoon Targeted gene correction by single-stranded oligodeoxynucleotides
US20020123474A1 (en) * 2000-10-04 2002-09-05 Shannon Mark E. Human GTP-Rho binding protein2
US7560622B2 (en) 2000-10-06 2009-07-14 Pioneer Hi-Bred International, Inc. Methods and compositions relating to the generation of partially transgenic organisms
US7491534B2 (en) 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
MXPA03005624A (es) * 2000-12-22 2004-12-03 Vaurox Llc Metodos para clonar mamiferos usando cromatina reprogramada del donador o celulas donadoras.
US20020142397A1 (en) * 2000-12-22 2002-10-03 Philippe Collas Methods for altering cell fate
WO2002059337A1 (en) * 2001-01-26 2002-08-01 Georgetown University School Of Medicine Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof
WO2002079495A2 (en) * 2001-03-27 2002-10-10 University Of Delaware Genomics applications for modified oligonucleotides
AU2002303262A1 (en) * 2001-04-06 2002-10-21 Georgetown University Gene shinc-1 and diagnostic and therapeutic uses thereof
AU2002258728A1 (en) 2001-04-06 2002-10-21 Georgetown University Gene brcc-3 and diagnostic and therapeutic uses thereof
WO2002081639A2 (en) * 2001-04-06 2002-10-17 Georgetown University Gene brcc2 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en) * 2001-04-06 2002-10-21 Georgetown University Gene scc-112 and diagnostic and therapeutic uses thereof
US20030045830A1 (en) * 2001-04-17 2003-03-06 De Bizemont Therese Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
US20040063922A1 (en) * 2001-04-17 2004-04-01 Conrad Charles A. Methods and compositions for catalytic DNA exchange in a sequence specific manner
US7053195B1 (en) * 2001-06-12 2006-05-30 Syngenta Participatious Ag Locked nucleic acid containing heteropolymers and related methods
CA2633171C (en) 2001-06-20 2012-11-20 Genentech, Inc. Antibodies against tumor-associated antigenic target (tat) polypeptides
US7803915B2 (en) 2001-06-20 2010-09-28 Genentech, Inc. Antibody compositions for the diagnosis and treatment of tumor
AU2002315393A1 (en) 2001-06-21 2003-01-08 Isis Pharmaceuticals, Inc. Antisense modulation of superoxide dismutase 1, soluble expression
EP1925672A1 (de) 2001-06-22 2008-05-28 Syngeta Participations AG Auf abiotischen Stress ansprechende Polynukleotide und Polypeptide
US6964950B2 (en) 2001-07-25 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of C-reactive protein expression
US7425545B2 (en) 2001-07-25 2008-09-16 Isis Pharmaceuticals, Inc. Modulation of C-reactive protein expression
US20030096772A1 (en) 2001-07-30 2003-05-22 Crooke Rosanne M. Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression
US7407943B2 (en) 2001-08-01 2008-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein B expression
WO2003013437A2 (en) * 2001-08-07 2003-02-20 University Of Delaware Compositions and methods for the prevention and treatment of huntington's disease
US7227014B2 (en) 2001-08-07 2007-06-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein (a) expression
US20030084473A1 (en) * 2001-08-09 2003-05-01 Valigen Non-transgenic herbicide resistant plants
US7456335B2 (en) * 2001-09-03 2008-11-25 Basf Plant Science Gmbh Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
ES2431929T3 (es) 2001-09-18 2013-11-28 Genentech, Inc. Composiciones y procedimientos para el diagnóstico y el tratamiento de tumores
WO2003025220A2 (en) 2001-09-18 2003-03-27 Carnegie Institution Of Washington Fusion proteins useful for detecting analytes
US7468244B2 (en) * 2001-09-27 2008-12-23 University Of Delaware Polymorphism detection and separation
CA2461844C (en) 2001-09-27 2011-04-05 Pioneer Hi-Bred International, Inc. Phytate polynucleotides and methods of use
WO2003027264A2 (en) * 2001-09-27 2003-04-03 University Of Delaware Coisogenic eukaryotic cell collections
AU2002341905A2 (en) * 2001-09-27 2003-04-07 University Of Delaware Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration
ATE516364T1 (de) 2001-10-09 2011-07-15 Isis Pharmaceuticals Inc Antisense-modulation der expression des insulinähnlicher-wachstumsfaktor-bindungsprotei s 5
US6750019B2 (en) 2001-10-09 2004-06-15 Isis Pharmaceuticals, Inc. Antisense modulation of insulin-like growth factor binding protein 5 expression
US6965025B2 (en) 2001-12-10 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of connective tissue growth factor expression
CA2471431A1 (en) 2002-01-02 2003-07-17 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
IL152904A0 (en) 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
EP1465982A4 (de) 2002-01-25 2006-06-07 Gamida Cell Ltd Verfahren zur expansion von stamm- und vorläuferzellen und damit erhaltene expandierte zellpopulationen
ATE443133T1 (de) 2002-02-01 2009-10-15 Life Technologies Corp Oligonukleotidzusammensetzungen mit verbesserter effizienz
EP1572902B1 (de) 2002-02-01 2014-06-11 Life Technologies Corporation HOCHWIRKSAME siRNAS ZUR REDUZIERUNG DER EXPRESSION VON ZIELGENEN
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
US7135326B2 (en) * 2002-02-07 2006-11-14 E. I. Du Pont De Nemours And Company UDP-glucosyltransferases
WO2003069984A2 (en) 2002-02-20 2003-08-28 American Integrated Biologics, Inc. Transgenic production in saliva
CA2478479A1 (en) * 2002-03-07 2003-09-18 University Of Delaware Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phagebeta protein, or hydroxyurea
WO2003087313A2 (en) 2002-04-08 2003-10-23 Pioneer Hi-Bred International, Inc. Enhanced silk exsertion under stress
US7244565B2 (en) * 2002-04-10 2007-07-17 Georgetown University Gene shinc-3 and diagnostic and therapeutic uses thereof
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
EP1571968A4 (de) 2002-04-16 2007-10-17 Genentech Inc Zusammensetzungen und verfahren zur diagnose und behandlung von tumoren
US7432342B2 (en) 2002-05-03 2008-10-07 Sequenom, Inc. Kinase anchor protein muteins, peptides thereof and related documents
WO2003095655A2 (de) 2002-05-08 2003-11-20 Basf Plant Science Gmbh Verfahren zum erhöhen des ölgehaltes in pflanzen
US20030228317A1 (en) * 2002-05-22 2003-12-11 Prafulla Gokhale Gene BRCC-1 and diagnostic and therapeutic uses thereof
US7199107B2 (en) 2002-05-23 2007-04-03 Isis Pharmaceuticals, Inc. Antisense modulation of kinesin-like 1 expression
US20030228558A1 (en) * 2002-06-11 2003-12-11 Bloom William Dennis Method of training brokers in a multi-level marketing business
AU2003231912A1 (en) * 2002-06-12 2003-12-31 Tel Aviv Medical Center Research Development Fund Methods of detecting and treating prostate cancer
AU2003264507A1 (en) * 2002-09-20 2004-04-08 Koken Co., Ltd. Site-specific gene conversion promoter and gene therapeutic
WO2004031350A2 (en) 2002-09-26 2004-04-15 Amgen, Inc. Modulation of forkhead box o1a expression
AU2003282477A1 (en) * 2002-10-07 2004-05-04 Napro Bio Therapeutics, Inc. Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration
CA2504929C (en) 2002-11-05 2014-07-22 Charles Allerson Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
US9150605B2 (en) * 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
US9150606B2 (en) 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
CA2504720C (en) 2002-11-05 2013-12-24 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
RU2384059C2 (ru) * 2002-11-08 2010-03-20 Киова Хакко Кирин Ко., Лтд. Трансгенные копытные животные, имеющие пониженную активность прионного белка, и их применения
WO2004044181A2 (en) 2002-11-13 2004-05-27 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein b expression
ES2420914T3 (es) 2002-11-13 2013-08-27 Genzyme Corporation Modulación antisentido de la expresión de la apolipoproteína B
JP4555089B2 (ja) 2002-11-15 2010-09-29 モーフオテク・インコーポレーテツド invitro免疫感作により創製されたハイブリドーマからの抗体の高生産量の生成方法
US7144999B2 (en) 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
SI1578973T1 (sl) 2002-12-19 2009-02-28 Bayer Cropscience Ag Rastlinske celice in rastline, ki sintetizirajo škrob s povečano končno viskoznostjo
CA2515484C (en) 2003-02-11 2011-09-20 Antisense Therapeutics Ltd Modulation of insulin like growth factor i receptor expression
AU2004213800A1 (en) 2003-02-17 2004-09-02 Metanomics Gmbh Preparation of organisms with faster growth and/or higher yield
US7803781B2 (en) 2003-02-28 2010-09-28 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
US20040185559A1 (en) 2003-03-21 2004-09-23 Isis Pharmaceuticals Inc. Modulation of diacylglycerol acyltransferase 1 expression
EP2365063B1 (de) 2003-03-31 2015-10-14 University Of Bristol Neue pflanzliche Acyltransferase spezifisch für langkettige mehrfach ungesättigte Fettsäuren
US20040205840A1 (en) * 2003-04-11 2004-10-14 Pioneer Hi-Bred International, Inc. Method for reducing gene expression
AU2004230490C1 (en) 2003-04-15 2012-08-16 Basf Plant Science Gmbh Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
US7598227B2 (en) 2003-04-16 2009-10-06 Isis Pharmaceuticals Inc. Modulation of apolipoprotein C-III expression
US7399853B2 (en) 2003-04-28 2008-07-15 Isis Pharmaceuticals Modulation of glucagon receptor expression
EP1633307A4 (de) 2003-06-03 2009-06-24 Isis Pharmaceuticals Inc Modulation der survivin-expression
WO2004113496A2 (en) * 2003-06-20 2004-12-29 Isis Pharmaceuticals, Inc. Double stranded compositions comprising a 3’-endo modified strand for use in gene modulation
US7683036B2 (en) 2003-07-31 2010-03-23 Regulus Therapeutics Inc. Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
BRPI0413118A (pt) 2003-08-01 2006-10-03 Basf Plant Science Gmbh construção de ácido nucleico, vetor, célula hospedeira, processo para a produção de um polipeptìdeo, polipeptìdeo, anticorpo, tecido vegetal, material de propagação, material coletado ou uma planta, método para a avaliação de agonistas e antagonistas de uma atividade de um poliptìdeo codificado pela molécula de ácido nucleico, processo para a identificação de um composto que confere produção de produto quìmico fino aumentada em uma planta ou microorganismo, método para a identificação de um produto genético que confere um aumento na produção de produto quìmico fino em uma célula, método para a produção de uma composição agrìcola, composição, e, uso da molécula de ácido nucleico, do polipeptìdeo, ou da construção de ácido nucleico, ou do produto genético identificado
ES2590077T3 (es) 2003-08-01 2016-11-18 Basf Plant Science Gmbh Procedimiento para la producción de ácidos grasos poliinsaturados en organismos transgénicos
PT1654276E (pt) 2003-08-11 2013-03-25 Kweek En Researchbed Agrico Bv Plantas resistentes a fungos e seus usos
US7825235B2 (en) 2003-08-18 2010-11-02 Isis Pharmaceuticals, Inc. Modulation of diacylglycerol acyltransferase 2 expression
US20050053981A1 (en) 2003-09-09 2005-03-10 Swayze Eric E. Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
EP2256201A3 (de) 2003-09-18 2012-07-04 Isis Pharmaceuticals, Inc. Modulation der eIF4E expression
PL1678194T3 (pl) 2003-10-10 2014-01-31 Alchemia Oncology Pty Ltd Modulowanie syntezy i degradacji hialuronianu w leczeniu choroby
CN1910293B (zh) 2003-10-23 2011-04-13 伊洛默格生物科学公司 检测与抗病毒感染性有关的基因oas1中的突变的方法
US20050191653A1 (en) 2003-11-03 2005-09-01 Freier Susan M. Modulation of SGLT2 expression
NZ547558A (en) 2003-11-17 2009-06-26 Genentech Inc Compositions and methods for the treatment of tumor of hematopoietic origin
US20050120397A1 (en) * 2003-11-24 2005-06-02 Hermann Steller Compounds and methods for regulation of spermatid differentiation
RU2006125376A (ru) 2003-12-17 2008-01-27 КРОПДИЗАЙН Н.Фи. (BE) Растения с модифицированными характеристиками роста и способ их получения
US7695932B2 (en) * 2003-12-24 2010-04-13 Massachusetts Institute Of Technology Gene targets for enhanced carotenoid production
US7741070B2 (en) 2003-12-24 2010-06-22 Massachusetts Institute Of Technology Gene targets for enhanced carotenoid production
US7608699B2 (en) * 2003-12-29 2009-10-27 Rockefeller University Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof
EP1711606A2 (de) 2004-01-20 2006-10-18 Isis Pharmaceuticals, Inc. Modulation der expression des glucocorticoidrezeptors
US7468431B2 (en) 2004-01-22 2008-12-23 Isis Pharmaceuticals, Inc. Modulation of eIF4E-BP2 expression
EP1718751B1 (de) 2004-02-25 2013-05-01 Pioneer-Hi-Bred International, Inc. Neue bacillus thuringiensis-kristallpolypeptide, -polynukleotide sowie zusammensetzungen davon
EP2623584B1 (de) 2004-02-27 2019-04-10 BASF Plant Science GmbH Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in transgenen Pflanzen
AU2005217080B2 (en) 2004-02-27 2011-02-24 Basf Plant Science Gmbh Method for producing unsaturated omega-3 fatty acids in transgenic organisms
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
EP2700720A3 (de) 2004-03-15 2015-01-28 Isis Pharmaceuticals, Inc. Zusammensetzungen und Verfahren zur Optimierung der Spaltung von RNA durch RNase H
US8314226B2 (en) * 2004-03-29 2012-11-20 The General Hospital Corporation Oligonucleotide complex compositions and methods of use as gene alteration tools
JP2007531794A (ja) 2004-04-05 2007-11-08 アルニラム ファーマスーティカルズ インコーポレイテッド オリゴヌクレオチドの合成および精製に使用する方法および反応試薬
US20050244869A1 (en) 2004-04-05 2005-11-03 Brown-Driver Vickie L Modulation of transthyretin expression
JP2007533328A (ja) 2004-04-22 2007-11-22 キリンホールディングス株式会社 トランスジェニック動物及びその用途
US20070072815A1 (en) * 2004-05-04 2007-03-29 Kmiec Eric B Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
US7825293B2 (en) 2004-05-28 2010-11-02 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
ES2352172T3 (es) 2004-06-09 2011-02-16 Pioneer-Hi-Bred International, Inc. Péptidos de transito de plastidio.
AU2005321630A1 (en) 2004-07-02 2006-07-06 Metanomics Gmbh Process for the production of fine chemicals
WO2007087815A2 (en) 2004-12-17 2007-08-09 Metanomics Gmbh Process for the control of production of fine chemicals
US8680062B2 (en) 2004-07-06 2014-03-25 Deliversir Ltd. System for delivering therapeutic agents into living cells and cells nuclei
CA2573443A1 (en) 2004-07-12 2006-01-19 Cropdesign N.V. Plants having improved growth characteristics and method for making the same
EP1774004B1 (de) 2004-07-31 2013-07-10 Metanomics GmbH Herstellung von organismen mit schnellerem wachstum und/oder höherem ertrag
PL2409713T3 (pl) 2004-08-10 2016-02-29 Kastle Therapeutics Llc Oligonukleotydy do zastosowania w modulowaniu poziomów lipoproteiny i cholesterolu u ludzi
EP1778845A2 (de) 2004-08-16 2007-05-02 CropDesign N.V. Pflanzen mit modifizierten wachstumseigenschaften und methoden für deren herstellung
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
EP1799812A4 (de) 2004-09-16 2009-09-09 Gamida Cell Ltd Verfahren zur ex-vivo-expansion von progenitor- und stammzellen durch gemeinsame kultivierung mit mesenchymzellen
EP2397563A3 (de) 2004-09-17 2012-07-18 Isis Pharmaceuticals, Inc. Verbesserte Antisense-Oligonukleotide
EP2053057A3 (de) 2004-09-24 2009-07-15 BASF Plant Science GmbH Nukleinsäuresequenzkodierende Proteine in Zusammenhang mit abiotischer Stressreaktion und Pflanzenzellen mit erhöhter Umweltstressverträglichkeit
NZ554277A (en) 2004-10-20 2010-09-30 Antisense Therapeutics Ltd Antisense modulation of integrin alpha 4 expression
AU2005298638B2 (en) 2004-10-29 2011-03-31 Cropdesign N.V. Plants having improved growth characteristics and method for making the same
AR051866A1 (es) 2004-12-24 2007-02-14 Cropdesign Nv Plantas con aumento del rendimiento y metodo de prepracion
CA2592894C (en) 2004-12-28 2013-08-27 Pioneer Hi-Bred International, Inc. Improved grain quality through altered expression of gamma-zein protein
BRPI0607211A2 (pt) 2005-01-27 2009-12-22 Cropdesign Nv métodos para incrementar rendimento de planta relativamente a plantas correspondentes de tipo selvagem, para incrementar rendimento, particularmente rendimento de sementes, relativamente àquele de plantas correspondentes de tipo selvagem e para a produção de uma planta transgênica, planta, parte de planta ou célula de planta, construção, planta transgênica ou parte da mesma, partes colhìveis, produtos, e, uso de um gene/ácido nucleico de syt ou variante do mesmo, ou uso de um polipeptìdeo de syt ou homólogo do mesmo, ou uso de uma construção
BRPI0519985B1 (pt) 2005-02-23 2018-01-30 University Of Kentucky Research Foundation Método para redução do nível de nornicotina ou n’-nitrosonornicotina em uma planta do gênero nicotiana ou parte desta ou em um produto de tabaco, cassete de expressão e método para a produção de uma planta do gênero nicotiana
CA2598792A1 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
US20140199313A1 (en) 2005-03-02 2014-07-17 Metanomics Gmbh Process for the Production of Fine Chemicals
EP2166100B1 (de) 2005-03-08 2012-07-18 BASF Plant Science GmbH Expressionsverstärkende Intronsequenzen
EP1869076A2 (de) 2005-03-10 2007-12-26 Genentech, Inc. Verfahren und zusammensetzungen zur modulation der gefässintegrität
DE102005013779A1 (de) 2005-03-22 2006-09-28 Basf Plant Science Gmbh Verfahren zur Herstellung von mehrfach ungesättigten C20- und C22-Fettsäuren mit mindestens vier Doppelbindungen in transgenen Pflanzen
EP1707632A1 (de) 2005-04-01 2006-10-04 Bayer CropScience GmbH Phosphorylierte waxy-Kartoffelstärke
US8349991B2 (en) 2005-04-19 2013-01-08 Massachusetts Institute Of Technology Amphiphilic polymers and methods of use thereof
WO2006111512A1 (en) 2005-04-19 2006-10-26 Basf Plant Science Gmbh Improved methods controlling gene expression
US20070011752A1 (en) * 2005-05-06 2007-01-11 American Integrated Biologics, Inc. Production of human proteins in transgenic animal saliva
CA2614915A1 (en) 2005-05-25 2006-11-30 Pioneer Hi-Bred International, Inc. Methods for improving crop plant architecture and yield
EP1891141B1 (de) 2005-05-31 2016-11-16 Ecole Polytechnique Fédérale de Lausanne (EPFL) Triblockcopolymere zur zytoplasmatischen zuführung von arzneistoffen auf genbasis
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
EP2159289A3 (de) 2005-06-23 2010-03-24 BASF Plant Science GmbH Verbessertes Verfahren zur Herstellung stabil transformierter Pflanzen
EP2431472A1 (de) 2005-07-06 2012-03-21 CropDesign N.V. Pflanzenertragsverbesserung duch STE20-artige Genexpression
DE102005038036A1 (de) 2005-08-09 2007-02-15 Basf Plant Science Gmbh Verfahren zur Herstellung von Arachidonsäure und/oder Eicosapentaensäure in transgenen Nutzpflanzen
EP1915452A2 (de) 2005-08-12 2008-04-30 BASF Plant Science GmbH Für mit einer reaktion auf abiotischen stress assoziierte proteine codierende nukleinsäuresequenzen sowie pflanzenzellen und pflanzen mit erhöhter toleranz gegenüber umweltstress
US7842856B2 (en) 2005-08-25 2010-11-30 The Board Of Trustees Of The University Of Illinois Herbicide resistance gene, compositions and methods
BRPI0615941A2 (pt) 2005-09-15 2011-05-31 Cropdesign Nv método para aumentar o rendimento de planta em relação às plantas de controle, planta, construção, método para a produção de uma planta transgênica, planta transgênica, partes colhìveis de uma planta, produtos, uso de um ácido nucleico/gene oslea3a ou variante do mesmo ou uso de um polipeptìdeo oslea3a ou um homólogo do mesmo, e, semente de planta
WO2007039454A1 (en) 2005-09-20 2007-04-12 Basf Plant Science Gmbh Methods for controlling gene expression using ta-siran
GB2431158A (en) 2005-10-13 2007-04-18 Rothamsted Res Ltd Process for the production of arachidonic and/or eicosapentaenoic acid
WO2007051866A2 (en) 2005-11-07 2007-05-10 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
US8853492B2 (en) 2005-11-07 2014-10-07 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
US8362323B2 (en) * 2005-11-08 2013-01-29 Basf Plant Science Gmbh Use of armadillo repeat (ARM1) polynucleotides for obtaining pathogen resistance in plants
US20090222952A1 (en) 2005-11-08 2009-09-03 Cropdesign N.V. Plants Having Improved Growth Characteristics And A Method For Making The Same
CA2629521A1 (en) 2005-11-10 2007-05-24 Pioneer Hi-Bred International, Inc. Dof (dna binding with one finger) sequences and methods of use
US20070199096A1 (en) 2005-11-14 2007-08-23 E.I. Du Pont De Nemours And Company Compositions and Methods for Altering Alpha- and Beta-Tocotrienol Content
AU2006318194B2 (en) 2005-11-21 2012-08-09 Isis Pharmaceuticals, Inc. Modulation of eiF4E-BP2 expression
JP2009519009A (ja) * 2005-11-24 2009-05-14 ビーエーエスエフ ソシエタス・ヨーロピア キメラケラチン結合エフェクタータンパク質
US7723574B2 (en) 2005-11-24 2010-05-25 Basf Plant Science Gmbh Process for the production of Δ5-unsaturated fatty acids in transgenic organisms
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
EP2166106B1 (de) 2005-12-01 2015-02-25 CropDesign N.V. Pflanzen mit verbesserten Wachstumseigenschaften und Verfahren zu deren Herstellung
JP2009521213A (ja) 2005-12-24 2009-06-04 ティーガスク デイリー プロダクツ リサーチ センター トランス−10,シス−12オクタデカジエン酸を製造する方法
CN103301475B (zh) 2005-12-28 2016-08-03 斯克里普斯研究所 药物组合物和表达载体以及调节基因表达的方法和核酸分子的应用
US7592505B2 (en) 2005-12-30 2009-09-22 Pioneer Hi-Bred International, Inc. UDP-xylose synthases (UXS) polynucleotides, polypeptides, and uses thereof
WO2007080143A1 (en) 2006-01-12 2007-07-19 Basf Plant Science Gmbh Use of stomatin (stm1) polynucleotides for achieving a pathogen resistance in plants
EP2923563A3 (de) 2006-01-12 2015-10-14 Cibus Europe B.V. EPSPS-Mutanten
US7951934B2 (en) 2006-01-26 2011-05-31 Isis Pharmaceuticals, Inc. Compositions and their uses directed to huntingtin
CA2640058C (en) 2006-01-27 2018-04-24 Isis Pharmaceuticals, Inc. Oligomeric compounds and compositions for the use in modulation of micrornas
US7569686B1 (en) 2006-01-27 2009-08-04 Isis Pharmaceuticals, Inc. Compounds and methods for synthesis of bicyclic nucleic acid analogs
EP2314594B1 (de) 2006-01-27 2014-07-23 Isis Pharmaceuticals, Inc. 6-Modifizierte bicyclische Nukleinsäureanaloga
BRPI0707413A2 (pt) 2006-02-09 2011-05-03 Pioneer Hi Bred Int genes para aprimoramento da eficiência de utilização do nitrogênio em culturas
GB0603160D0 (en) 2006-02-16 2006-03-29 Rothamsted Res Ltd Nucleic acid
BRPI0708976A2 (pt) 2006-03-24 2011-07-05 Basf Plant Science Gmbh célula de planta, planta, semente, molécula de ácido nucleico isolada, construção de ácido nucleico, vetor, célula hospedeira, proteìna relacionada com estresse isolada, métodos para produzir uma planta transgênica e para modificar a toleráncia a estresse de uma planta, e, usos de um ácido nucleico codificando srp e de toleráncia e/ou resistência aumentadas a estresse ambiental e/ou um ácido nucleico codificando srp
EP2004829B1 (de) 2006-03-31 2012-08-01 BASF Plant Science GmbH Pflanzen mit verbesserten ertragseigenschaften und verfahren zu ihrer herstellung
EP2090662A3 (de) 2006-04-05 2012-10-31 Metanomics GmbH Verfahren zur Herstellung einer feinen Chemikalie
CA2649734A1 (en) 2006-04-19 2007-11-01 Pioneer Hi-Bred International, Inc. Isolated polynucleotide molecules corresponding to mutant and wild-type alleles of the maize d9 gene and methods of use
KR101441700B1 (ko) 2006-05-05 2014-09-18 아이시스 파마수티컬즈 인코포레이티드 Pcsk9 발현을 조절하는 화합물 및 방법
US7666854B2 (en) 2006-05-11 2010-02-23 Isis Pharmaceuticals, Inc. Bis-modified bicyclic nucleic acid analogs
ES2389737T3 (es) 2006-05-11 2012-10-31 Isis Pharmaceuticals, Inc. Análogos de ácidos nucleicos bicíclicos modificados en 5'
MX2008015093A (es) 2006-05-30 2009-02-25 Cropdesign Nv Plantas que tienen caracteristicas relacionadas con rendimiento mejorado y un metodo para formar las mismas.
CN101460517B (zh) 2006-05-31 2013-11-06 梅坦诺米克斯有限公司 使用铵转运蛋白或者葡萄糖-6-磷酸脱氢酶或者法呢基磷酸合成酶(fpp)的氮代谢操作
WO2007141189A2 (en) 2006-06-08 2007-12-13 Basf Plant Science Gmbh Plants having improved growth characteristics and method for making the same
AR069996A1 (es) 2006-06-15 2010-03-10 Cropdesign Nv Plantas con caracteristicas aumentadas relacionadas con el rendimiento y un metodo para desarrollar las mismas
EP2599870A3 (de) 2006-06-15 2013-09-11 CropDesign N.V. Pflanzen mit verbesserten Ertragseigenschaften und Verfahren zu ihrer Herstellung
JP2009542847A (ja) 2006-06-28 2009-12-03 サイバス,エルエルシー 脂肪酸ブレンド及びその使用
WO2008011473A2 (en) 2006-07-19 2008-01-24 Isis Pharmaceuticals, Inc. Compositions and their uses directed to hbxip
EP2543733A1 (de) 2006-08-02 2013-01-09 CropDesign N.V. Pflanzen mit verbesserten Eigenschaften und Verfahren zu ihrer Herstellung
EP2189533A1 (de) 2006-08-02 2010-05-26 CropDesign N.V. Pflanzen mit verbesserten Eigenschaften bezüglich des Ertrags und Verfahren zu ihrer Herstellung
EP2059600B1 (de) 2006-08-30 2014-04-02 BASF Plant Science GmbH Verfahren zur erhöhung der pathogenresistenz in transgenen pflanzen
US9127084B2 (en) 2006-09-14 2015-09-08 Medgenics Medical Israel Ltd. Long lasting drug formulations
CA2664318C (en) 2006-09-14 2017-05-23 Andrew L. Pearlman Long lasting drug formulations
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
US8710299B2 (en) 2006-10-06 2014-04-29 Basf Plant Science Gmbh Processes for producing polyunsaturated fatty acids in transgenic organisms
EP2487245A3 (de) 2006-10-12 2012-10-24 BASF Plant Science GmbH Verfahren zur Erhöhung der Pathogenresistenz in transgenen Pflanzen
EP2121936A2 (de) 2006-10-13 2009-11-25 BASF Plant Science GmbH Pflanzen mit erhöhtem ertrag
BRPI0720192A2 (pt) 2006-10-24 2013-12-31 Basf Plant Science Gmbh Método para gerar ou aumentar uma resistência a pelo menos um fungo biotrófico em uma planta ou uma parte de uma planta, seqüência de polipeptídio artificial, seqüência de ácido nucléico artificial, cassete de expressão recombinante, vetor recombinante, e, microorganismo recombinante
MX2009005160A (es) 2006-11-16 2009-05-28 Basf Plant Science Gmbh Plantas que tienen rasgos relacionados con rendimiento mejorados y un metodo para hacer las mismas usando secuencias de consenso de la familia de proteina y abby.
WO2008062049A1 (en) 2006-11-24 2008-05-29 Cropdesign N.V. Transgenic plants comprising as transgene a class i tcp or clavata 1 (clv1) or cah3 polypeptide having increased seed yield and a method for making the same
MX2009005514A (es) 2006-12-15 2009-06-04 Cropdesign Nv Plantas que presentan un incremento de sus rasgos relacionados con el rendimiento y un metodo para producirlas.
WO2008074891A2 (en) 2006-12-21 2008-06-26 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for method for making the same
EP1935428A1 (de) * 2006-12-22 2008-06-25 Antisense Pharma GmbH Oligonukleotid-Polymer Konjugate
EA023910B1 (ru) 2006-12-28 2016-07-29 Пайонир Хай-Бред Интернэшнл, Инк. Способ идентификации растения подсолнечника или зародышевой плазмы подсолнечника, имеющего устойчивость к orobanche
WO2008085191A1 (en) * 2007-01-10 2008-07-17 Purdue Research Fundation Polypeptide inhibitors of hsp27 kinase and uses therefor
CA2673361A1 (en) 2007-01-15 2008-07-24 Basf Plant Science Gmbh Use of subtilisin (rnr9) polynucleotides for achieving a pathogen resistance in plants
WO2008092910A1 (en) 2007-01-30 2008-08-07 Cropdesign N.V. Plants having enhanced yield-related traits and a method for making the same
EP2275560A3 (de) 2007-01-31 2012-01-25 BASF Plant Science GmbH Transgene Pflanzen, enthaltend als Transgen ein Mitglied der REMORIN Gen Familie oder eine Konsenssequenz davon, mit verbesserten Eigenschaften bezüglich des Ertrags und Verfahren zu ihrer Herstellung
CA2691066C (en) 2007-02-09 2018-07-31 Northwestern University Particles for detecting intracellular targets
EP2711425A1 (de) 2007-02-28 2014-03-26 CropDesign N.V. Pflanzen mit verbesserten Eigenschaften bezüglich des Ertrags und verfahren zu ihrer Herstellung
WO2008118394A1 (en) 2007-03-23 2008-10-02 New York University Methods of affecting nitrogen assimilation in plants
EA021541B9 (ru) 2007-04-04 2017-04-28 Басф Плант Сайенс Гмбх Рекомбинантный или мутантный полинуклеотид для придания растениям толерантности к гербицидам, ингибирующим ацетогидроксикислотную синтазу (ahas) (варианты), растение, не встречающееся в природе, и его семена, способ борьбы с сорняками, способ получения трансгенного растения, толерантного к соединениям, ингибирующим ahas, способ идентификации или отбора клетки растения, ткани растения или растения или части растения, способ предотвращения нежелательного вегетативного роста и способ идентификации растения
US9156865B2 (en) 2007-04-23 2015-10-13 Deliversir Ltd System for delivering therapeutic agents into living cells and cells nuclei
US9556210B2 (en) 2007-04-23 2017-01-31 Sabag-Rfa Ltd. System for delivering therapeutic agents into living cells and cells nuclei
PT2144633E (pt) * 2007-04-23 2014-10-27 Deliversir Ltd Um sistema para a administração de agentes terapêuticos em células vivas e núcleos de células
WO2008137108A2 (en) 2007-05-03 2008-11-13 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
DE112008001453T5 (de) 2007-05-22 2010-04-29 Basf Plant Science Gmbh Pflanzenzellen und Pflanzen mit erhöhter Toleranz und/oder Resistenz gegenüber Umweltstress und erhöhter Biomasseproduktion-KO
MX2009012556A (es) 2007-05-22 2010-02-18 Basf Plant Science Gmbh Plantas con mayor tolerancia y/o resistencia al estres ambiental y mayor produccion de biomasa.
US8878006B2 (en) 2007-05-23 2014-11-04 Crop Design N.V. Plants having enhanced yield-related traits and a method for making the same
CA2687211A1 (en) 2007-05-25 2008-12-04 Cropdesign N.V. Yield enhancement in plants by modulation of maize alfins
CA2689923A1 (en) 2007-05-30 2008-12-11 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
AU2008260277C1 (en) 2007-05-30 2014-04-17 Isis Pharmaceuticals, Inc. N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
US8278426B2 (en) 2007-06-08 2012-10-02 Isis Pharmaceuticals, Inc. Carbocyclic bicyclic nucleic acid analogs
CN102027120A (zh) 2007-06-29 2011-04-20 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于制备该植物的方法
WO2009006478A2 (en) 2007-07-05 2009-01-08 Isis Pharmaceuticals, Inc. 6-disubstituted bicyclic nucleic acid analogs
CA2692777A1 (en) 2007-07-20 2009-01-29 Basf Plant Science Gmbh Plants having increased yield-related traits and a method for making the same
BRPI0813884A2 (pt) 2007-07-31 2014-10-07 Basf Plant Science Gmbh Método para intensificar características relacionadas com o rendimento em plantas com relação às plantas de controle, construção, uso de uma construção, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica, planta transgênica, partes colhíveis de uma planta, produtos, e, uso de um ácido nucleico.
AR067748A1 (es) 2007-07-31 2009-10-21 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas
DK2185698T3 (en) 2007-08-07 2015-07-27 Purdue Research Foundation Kinase Inhibitors and Uses thereof
EP2188298B1 (de) 2007-08-15 2013-09-18 Isis Pharmaceuticals, Inc. Tetrahydropyrannukleinsäureanaloga
EP2205748A1 (de) 2007-09-14 2010-07-14 BASF Plant Science GmbH Pflanzen mit verstärkten ertragsbezogenen merkmalen und verfahren zur herstellung davon
CN103695459A (zh) 2007-09-18 2014-04-02 巴斯夫植物科学有限公司 产量提高的植物
MX2010002463A (es) 2007-09-21 2010-03-29 Basf Plant Science Gmbh Plantas con rasgos relacionados con un rendimiento aumentado y un metodo para producirlas.
US7951785B2 (en) 2007-09-21 2011-05-31 California Institute Of Technology NFIA in glial fate determination, glioma therapy and astrocytoma treatment
BRPI0816880A2 (pt) 2007-09-21 2015-09-08 Basf Plant Science Gmbh métodos para produzir uma planta com rendimento aumentado em comparação com uma planta do tipo selvagem correspondente, para produzir uma planta transgênica com rendimento aumentado em comparação com uma planta do tipo selvagem não transformada correspondente, para produzir uma composição agrícola, para identificar uma planta com um rendimento aumentado, e para aumentar o rendimento de uma população de plantas, molécula de ácido nucleico isolada, construção de ácido nucléico, vetor, processos para produzir um polipeptídeo, e para identificar um composto, polipeptídeo, anticorpo, núcleo de célula de planta, célula de planta, tecido de planta, material de propagação, pólen, progênie, material colhido ou planta, semente, parte de planta, planta transgênica, planta transgênica, núcleo de célula de planta transgênica, célula de planta transgênica, planta que compreende um ou mais de tais núcleos de célula de planta transgênica ou células de planta, progênie, semente ou pólen derivado de ou produzido por uma planta transgênica, composição, e, uso dos ácidos nucleicos.
BR122018070228B1 (pt) 2007-10-05 2023-01-10 Cibus Europe B.V. Método para produção de planta brassica resistente à herbicida
WO2009045536A2 (en) * 2007-10-05 2009-04-09 The University Of North Carolina At Chapel Hill Receptor targeted oligonucleotides
US20110071047A1 (en) * 2007-10-27 2011-03-24 O.D. 260 Inc. Promoter detection and analysis
US20090111099A1 (en) * 2007-10-27 2009-04-30 Yongsheng Ma Promoter Detection and Analysis
MX2010004305A (es) 2007-10-29 2010-04-30 Basf Plant Science Gmbh Plantas que tienen rasgos relacionados con el rendimiento aumentado y un metodo para producirlas.
CN101939431B (zh) 2007-11-12 2015-01-28 北卡罗来纳州立大学 通过修饰特定细胞色素p450基因改变烟草生物碱含量
US8637478B2 (en) * 2007-11-13 2014-01-28 Isis Pharmaceuticals, Inc. Compounds and methods for modulating protein expression
EP2222851B1 (de) 2007-11-20 2017-06-28 Ionis Pharmaceuticals, Inc. Modulation der cd40-expression
AR069392A1 (es) 2007-11-20 2010-01-20 Pioneer Hi Bred Int Genes de senalizacion de etileno en maiz y su modulacion para aumentar la tolerancia al estres en plantas
US8546556B2 (en) * 2007-11-21 2013-10-01 Isis Pharmaceuticals, Inc Carbocyclic alpha-L-bicyclic nucleic acid analogs
CN103773795A (zh) 2007-11-22 2014-05-07 克罗普迪塞恩股份有限公司 具有增强的产量相关性状的植物及其生产方法
CN101883783A (zh) 2007-11-26 2010-11-10 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物及其制备方法
EP2222857A2 (de) 2007-12-19 2010-09-01 BASF Plant Science GmbH Pflanzen mit erhöhtem ertrag und/oder erhöhter toleranz gegenüber umweltstress (iy-bm)
DE112008003316T5 (de) 2007-12-20 2011-05-05 Basf Plant Science Gmbh Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben
CA2708499A1 (en) * 2007-12-21 2009-07-02 Basf Plant Science Gmbh Plants with increased yield (ko nue)
EA201070649A1 (ru) * 2007-12-27 2011-06-30 Сибас Ойлз Интернэшнл Л.П. Смеси алкиловых эфиров жирных кислот и их применение
CN103849647A (zh) 2008-01-25 2014-06-11 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于制备该植物的方法
RU2522480C2 (ru) 2008-01-31 2014-07-20 Нэшнл Инститьют Фо Байолоджикэл Сайенсес Растения с измененным ростом и/или развитием и способ их создания
WO2009100320A2 (en) 2008-02-07 2009-08-13 Isis Pharmaceuticals, Inc. Bicyclic cyclohexitol nucleic acid analogs
MX2010009010A (es) 2008-02-27 2010-09-09 Basf Plant Science Gmbh Plantas con mayor rendimiento.
EP2282744B1 (de) 2008-03-21 2018-01-17 Ionis Pharmaceuticals, Inc. Oligomere verbindungen mit trizyklischen nukleosiden und anwendungsverfahren dafür
US9290534B2 (en) 2008-04-04 2016-03-22 Ionis Pharmaceuticals, Inc. Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleoside
AR073534A1 (es) 2008-04-16 2010-11-17 Basf Plant Science Gmbh Plantas que tienen rasgos aumentados relacionados con el rendimiento y un metodo para obtenerlas
US20110061134A1 (en) 2008-05-05 2011-03-10 Basf Plant Science Gmbh Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
EA201071338A1 (ru) * 2008-05-23 2012-01-30 Сибас Ойлз, Ллс Получение сквалена с применением дрожжей
EP2297327A1 (de) 2008-06-20 2011-03-23 BASF Plant Science GmbH Pflanzen mit eigenschaften in verbindung mit verbessertem ertrag sowie verfahren zu deren herstellung
CN102131934B (zh) 2008-06-26 2014-03-12 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物及其制备方法
CN102143971A (zh) 2008-07-04 2011-08-03 巴斯夫植物科学有限公司 通过过表达编码tfl-1 样蛋白的多核苷酸而具有增强的产量相关性状的植物及其制备方法
BRPI0916207A2 (pt) 2008-07-17 2015-08-04 Basf Plant Science Gmbh Métodos para melhorar as características relacionadas com rendimento em plantas em relação às plantas de controle, e para produzir uma planta transgênica, construto, uso de um construto, planta, parte de planta ou célula de planta, planta trangênica, partes colhíveis de uma planta, produtos, uso de um ácido nucleico, molécula de ácido nucleico isolada, e, polipeptídeo isolado
WO2010012760A2 (en) 2008-07-31 2010-02-04 Basf Plant Science Gmbh Plants having modified growth characteristics and a method for making the same
US20110262485A1 (en) 2008-08-04 2011-10-27 University Of Miami Sting (stimulator of interferon genes), a regulator of innate immune responses
MX2011001899A (es) 2008-08-19 2011-04-05 Basf Plant Science Gmbh Plantas con aumento de rendimiento al aumentar o generar una o mas actividades en una planta o una de sus partes.
CA2733505A1 (en) 2008-08-20 2010-02-25 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
CN107083386A (zh) 2008-08-25 2017-08-22 埃克斯雷德制药有限公司 阻止结缔组织生长因子的反义核苷酸及其用途
EP2342337B1 (de) 2008-09-11 2015-05-27 Keygene N.V. Verfahren zur entwicklung diagnostischer marker
DE112009002267T5 (de) 2008-09-23 2012-01-19 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag (LT)
US8501805B2 (en) 2008-09-24 2013-08-06 Isis Pharmaceuticals, Inc. Substituted alpha-L-bicyclic nucleosides
WO2010036696A1 (en) 2008-09-24 2010-04-01 Isis Pharmaceuticals, Inc. Cyclohexenyl nucleic acid analogs
BRPI0918991A2 (pt) 2008-09-24 2017-09-19 Basf Plant Science Gmbh Métodos para intensificar traços relacionados com o rendimento em plantas em relação ás plantas de controle, e para produzir uma planta transgênica, planta, parte de planta ou célula de planta, construção, uso de uma construção, partes colhíveis de uma planta, produtos, uso em um ácido nucleico, molécula de ácido nucleico isolada, e, polipeptídeo isolado
CA2737939C (en) 2008-09-26 2021-04-27 Basf Agrochemical Products B.V. Herbicide-resistant ahas-mutants and methods of use
PT2379084T (pt) 2008-10-15 2018-02-19 Ionis Pharmaceuticals Inc Modulação da expressão do fator 11
CA2741302C (en) * 2008-10-20 2017-02-28 Moerae Matrix, Inc. Mapkap kinase inhibitor polypeptide for treating or preventing adhesions
WO2010046423A2 (en) 2008-10-22 2010-04-29 Basf Se Use of sulfonylurea herbicides on cultivated plants
AR075466A1 (es) 2008-10-22 2011-04-06 Basf Se Uso de herbicidas tipo auxina en plantas cultivadas
EP2350287A2 (de) 2008-10-23 2011-08-03 BASF Plant Science GmbH Verfahren zur herstellung einer transgenen zelle mit erhöhtem gamma-aminobuttersäure-(gaba-)gehalt
CN102264907A (zh) 2008-10-23 2011-11-30 巴斯夫植物科学有限公司 产量增加的植物(nue)
CA2741294C (en) 2008-10-24 2018-04-24 Isis Pharmaceuticals, Inc. 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
US8987435B2 (en) 2008-10-24 2015-03-24 Isis Pharmaceuticals, Inc. Oligomeric compounds and methods
EP2184351A1 (de) 2008-10-30 2010-05-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Polynukleotid-kondierende Caryophyllen-Synthase und ihre Verwendung
EP2821490A3 (de) 2008-10-30 2015-04-22 Pioneer Hi-Bred International Inc. Manipulation von Glutaminsynthetasen (GS) zur Verbesserung der Stickstoffnutzungseffizienz und des Kornertrags in höherentwickelten Pflanzen
BRPI0921061A2 (pt) 2008-11-12 2016-07-19 Basf Plant Science Gmbh métodos para intensificar tolerância a estresse abiótico e/ou intensificar características relacionadas ao rendimento em plantas com relação a uma planta de controle, e para produzir uma planta transgênica com tolerância a estresse abiótico e/ou características relacionadas ao rendimento para uma planta de controle, partes colhíveis, produtos, construto, planta, parte de planta, ou célula de planta, usos de um construto, e de um ácido nucleico, molécula de ácido nucleico isolada, e, polipeptídeo isolado
WO2010054513A1 (en) 2008-11-14 2010-05-20 Fujian Fuda Biotech Co. Ltd. A thermotolerant non-k12 escherichia coli phytase and its production
MX2011005429A (es) 2008-11-24 2011-06-21 Univ Northwestern Composiciones de nanoparticulas de arn polivalentes.
AU2009324213A1 (en) 2008-12-03 2011-07-07 Basf Plant Science Gmbh Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same
JP6099868B2 (ja) 2008-12-04 2017-03-22 クルナ・インコーポレーテッド サーチュイン1(sirt1)に対する天然アンチセンス転写物の抑制によるサーチュイン1関連疾患の治療
WO2010065867A1 (en) 2008-12-04 2010-06-10 Pioneer Hi-Bred International, Inc. Methods and compositions for enhanced yield by targeted expression of knotted1
CA2745329C (en) 2008-12-04 2022-07-12 Opko Curna, Llc Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
CN107338251A (zh) 2008-12-04 2017-11-10 库尔纳公司 通过抑制肿瘤抑制基因的天然反义转录物治疗肿瘤抑制基因相关性疾病
WO2010068692A1 (en) 2008-12-10 2010-06-17 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
ES2435572T3 (es) 2008-12-12 2013-12-20 Basf Plant Science Gmbh Desaturasas y proceso para la producción de ácidos grasos poliinsaturados en organismos transgénicos
US20110252508A1 (en) 2008-12-17 2011-10-13 Basf Plant Science Gmbh Plants Having Enhanced Yield-Related Traits and/or Abiotic Stress Tolerance and a Method for Making the Same
US8592386B2 (en) 2008-12-17 2013-11-26 Sarepta Therapeutics, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
EP2204086A1 (de) 2009-01-02 2010-07-07 Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK) Sechszeilige Gerste
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
CA2749163A1 (en) 2009-01-14 2010-07-22 The Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases
EP2845903A3 (de) 2009-01-28 2015-06-10 BASF Plant Science Company GmbH Pflanzen mit verbesserten Ertragseigenschaften und Verfahren zur Herstellung davon
EP2393825A2 (de) 2009-02-06 2011-12-14 Isis Pharmaceuticals, Inc. Oligomere verbindungen und verfahren
WO2010090969A1 (en) 2009-02-06 2010-08-12 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
US20110319476A1 (en) 2009-02-12 2011-12-29 Opko Curna, Llc Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
ES2560107T3 (es) 2009-02-12 2016-02-17 Curna, Inc. Tratamiento de enfermedades relacionadas con el factor neurotrófico derivado de cerebro (BDNF) por inhibición de transcrito antisentido natural para BDNF
AU2010217663A1 (en) 2009-02-25 2011-09-01 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
WO2010101818A1 (en) 2009-03-02 2010-09-10 Pioneer Hi-Bred International, Inc. Nac transcriptional activators involved in abiotic stress tolerance
US20110319317A1 (en) 2009-03-04 2011-12-29 Opko Curna, Llc Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
WO2010107733A2 (en) 2009-03-16 2010-09-23 Curna, Inc. Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2
EP2408920B1 (de) 2009-03-17 2017-03-08 CuRNA, Inc. Behandlung von erkrankungen im zusammenhang mit dem delta-like-1-homolog (dlk1) mittels hemmung des natürlichen antisense-transkripts gegen dlk1
EP2419510B1 (de) 2009-04-14 2015-09-16 Pioneer Hi-Bred International Inc. Modulation von acc-synthase verbessert pflanzenertrag unter niedrigstickstoffbedingungen
EP2421974A1 (de) 2009-04-21 2012-02-29 BASF Plant Science Company GmbH Rna-vermittelte induktion der genexpression in pflanzen
AU2010241034A1 (en) 2009-04-21 2011-11-24 Basf Plant Science Company Gmbh RNA-mediated induction of gene expression in plants
EP3248618A1 (de) 2009-04-22 2017-11-29 Massachusetts Institute Of Technology Angeborene immununterdrückung mit ermöglichung der wiederholten verabreichung von langen rna-molekülen
EP2957637A3 (de) 2009-04-29 2016-03-23 BASF Plant Science Company GmbH Pflanzen mit verbesserten ertragseigenschaften und verfahren zur herstellung davon
MX2011011454A (es) 2009-04-29 2011-11-18 Basf Plant Science Co Gmbh Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas.
EP2424987B1 (de) 2009-05-01 2017-11-15 CuRNA, Inc. Behandlung von hämoglobin (hbf / hbg) verwandten krankheiten durch die inhibition des natürlichen antisense transcripts zu hbf / hbg
US8779239B2 (en) 2009-05-04 2014-07-15 Pioneeri Hi-Bred International, Inc. Yield enhancement in plants by modulation of AP2 transcription factor
CA2760754A1 (en) 2009-05-06 2010-11-11 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and/or enhanced abiotic stress tolerance and a method for making the same
US9155754B2 (en) 2009-05-06 2015-10-13 Curna, Inc. Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1
JP6250930B2 (ja) 2009-05-06 2017-12-20 クルナ・インコーポレーテッド トリステトラプロリン(ttp)に対する天然アンチセンス転写物の抑制によるttp関連疾患の治療
CA2762369C (en) 2009-05-18 2021-12-28 Joseph Collard Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
KR101703695B1 (ko) 2009-05-22 2017-02-08 큐알엔에이, 인크. 전사 인자 e3(tfe3)에 대한 천연 안티센스 전사체의 억제에 의해 tfe3 및 인슐린 수용체 기질 2(irs2)의 치료
CA2764683A1 (en) 2009-05-28 2010-12-02 Joseph Collard Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
EP2443237B1 (de) 2009-06-16 2017-02-22 CuRNA, Inc. Behandlung von krankheiten im zusammenhang mit dem kollagengen durch hemmung des natürlichen antisense-transkripts zu einem kollagengens
EP2443238B1 (de) 2009-06-16 2017-03-22 CuRNA, Inc. Behandlung von erkrankungen im zusammenhang mit paraoxonase 1 (pon1) mittels hemmung des natürlichen antisense-transkripts gegen pon 1
CN104762316A (zh) 2009-06-19 2015-07-08 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
EP2446036B1 (de) 2009-06-24 2017-03-01 CuRNA, Inc. Behandlung von erkrankungen im zusammenhang mit tumornekrose faktor-rezeptor 2 (tnfr2) mittels hemmung des natürlichen antisense-transkripts gegen tnfr2
JP5907866B2 (ja) 2009-06-26 2016-04-26 クルナ・インコーポレーテッド ダウン症候群遺伝子に対する天然アンチセンス転写物の抑制によるダウン症候群遺伝子関連疾患の治療
AU2010273756A1 (en) 2009-06-30 2011-11-24 E. I. Du Pont De Nemours And Company Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding cytosolic pyrophosphatase
ATE550350T1 (de) 2009-07-10 2012-04-15 Univ Berlin Freie Rock2 und rock3, zwei neue gain-of-function- varianten der cytokininrezeptoren ahk2 und ahk3
EP2275564A1 (de) 2009-07-17 2011-01-19 Freie Universität Berlin Mittel und Verfahren zur Produktion von transgenen Pflanzen, die gegenüber Kohlhernie resistent sind
WO2011009801A1 (en) 2009-07-23 2011-01-27 Basf Plant Science Company Gmbh Plants with increased yield
IN2012DN00531A (de) 2009-07-24 2015-08-21 Pioneer Hi Bred Int
WO2011017132A2 (en) * 2009-07-27 2011-02-10 Purdue Research, Foundation Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
US9234199B2 (en) 2009-08-05 2016-01-12 Curna, Inc. Treatment of insulin gene (INS) related diseases by inhibition of natural antisense transcript to an insulin gene (INS)
WO2011017492A2 (en) 2009-08-05 2011-02-10 Pioneer Hi-Bred International, Inc. Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
EP2462153B1 (de) 2009-08-06 2015-07-29 Isis Pharmaceuticals, Inc. Bicyclische cyclohexosenukleinsäureanaloga
GB0914012D0 (en) 2009-08-11 2009-09-16 Plant Bioscience Ltd Stress tolerant plants
EA201200284A1 (ru) 2009-08-19 2013-03-29 Басф Плант Сайенс Компани Гмбх Растения, имеющие улучшенные характеристики, связанные с урожаем, и способ создания таких
WO2011022608A2 (en) 2009-08-20 2011-02-24 Pioneer Hi-Bred International, Inc. Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake
CA2771172C (en) 2009-08-25 2021-11-30 Opko Curna, Llc Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
MX2012002069A (es) 2009-08-31 2012-03-29 Basf Plant Science Co Gmbh Moleculas de acido nucleico regulatorias para aumentar la expresion genica especifica de semilla y/o preferencial de semilla en las plantas.
CN102482684B (zh) 2009-08-31 2015-11-25 巴斯夫植物科学有限公司 用于增强植物中组成型基因表达的调节性核酸分子
SG178872A1 (en) 2009-08-31 2012-04-27 Basf Plant Science Co Gmbh Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis
ES2599076T3 (es) 2009-09-02 2017-01-31 Genentech, Inc. Smoothened mutante y métodos de utilización del mismo
CN102648282A (zh) 2009-09-25 2012-08-22 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
EA201270440A1 (ru) 2009-09-25 2012-10-30 Басф Плант Сайенс Компани Гмбх Растения с улучшенными характеристиками урожайности и способ их получения
US20110252505A1 (en) 2009-10-02 2011-10-13 Pioneer Hi-Bred International, Inc. Down-Regulation of ACC Synthase for Improved Plant Performance
MX2012004617A (es) 2009-10-22 2012-05-08 Genentech Inc Metodos y composiciones para modular activacion de hepsina de proteina que estimula macrofago.
DE112010003738T5 (de) 2009-10-22 2013-08-14 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung
AR078829A1 (es) 2009-10-30 2011-12-07 Du Pont Plantas y semillas con niveles alterados de compuesto de almacenamiento, construcciones relacionadas y metodos relacionados con genes que codifican proteinas similares a las aldolasas bacterianas de la clase ii del acido 2,4- dihidroxi-hept-2-eno-1,7-dioico
CA2779099C (en) 2009-10-30 2021-08-10 Northwestern University Templated nanoconjugates
US8697858B2 (en) 2009-11-13 2014-04-15 Sarepta Therapeutics, Inc. Antisense antiviral compound and method for treating influenza viral infection
CN102753693B (zh) 2009-11-13 2015-01-28 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
WO2011061656A1 (en) 2009-11-17 2011-05-26 Basf Plant Science Company Gmbh Plants with increased yield
US8470568B2 (en) 2009-11-23 2013-06-25 Nucelis Inc. Methods and compositions for producing squalene using yeast
KR101884028B1 (ko) 2009-11-30 2018-08-01 제넨테크, 인크. Slc34a2 (tat211 = 서열 2)를 발현하는 종양의 치료 및 진단을 위한 항체
EP2513310B1 (de) 2009-12-16 2017-11-01 CuRNA, Inc. Behandlung von erkrankungen im zusammenhang mit dem membranengebundenen transkriptionsfaktor-peptidase-ort 1 (mbtps1) mittels hemmung des natürlichen antisense-transkripts gegen mbtps1
KR101891352B1 (ko) 2009-12-23 2018-08-24 큐알엔에이, 인크. 간세포 성장 인자(hgf)에 대한 천연 안티센스 전사체의 억제에 의한 hgf 관련 질환의 치료
US9068183B2 (en) 2009-12-23 2015-06-30 Curna, Inc. Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2
MX2012007581A (es) 2009-12-28 2012-07-30 Pioneer Hi Bred Int Genotipos restauradores de la fertilidad de sorgo y metodos de seleccion asistida por marcadores.
JP5982288B2 (ja) 2009-12-29 2016-08-31 カッパーアールエヌエー,インコーポレイテッド 腫瘍タンパク質63(p63)に対する天然アンチセンス転写物の阻害による腫瘍タンパク質63関連疾患の治療
CN102782134B (zh) 2009-12-29 2017-11-24 库尔纳公司 通过抑制核呼吸因子1(nrf1)的天然反义转录物而治疗nrf1相关疾病
US20110191903A1 (en) 2009-12-31 2011-08-04 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
WO2011082409A2 (en) 2010-01-04 2011-07-07 Curna, Inc. Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
US20110167517A1 (en) 2010-01-06 2011-07-07 Pioneer Hi-Bred International, Inc. Identification of diurnal rhythms in photosynthetic and non-photsynthetic tissues from zea mays and use in improving crop plants
JP5963680B2 (ja) 2010-01-06 2016-08-03 カッパーアールエヌエー,インコーポレイテッド 膵臓発生遺伝子に対する天然アンチセンス転写物の阻害による膵臓発生遺伝子疾患の治療
US8779118B2 (en) 2010-01-11 2014-07-15 Isis Pharmaceuticals, Inc. Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom
DK2524039T3 (en) 2010-01-11 2018-03-12 Curna Inc TREATMENT OF GENDER HORMON-BINDING GLOBULIN (SHBG) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENCE TRANSCRIPTS TO SHBG
WO2011091244A1 (en) 2010-01-21 2011-07-28 NellOne Therapeutics, Inc. Methods to treat or prevent a skin condition using a nell1 peptide
WO2011091390A2 (en) 2010-01-25 2011-07-28 Opko Curna, Llc Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
CA2788198C (en) 2010-01-26 2021-01-19 Pioneer Hi-Bred International, Inc. Hppd-inhibitor herbicide tolerance
KR101838308B1 (ko) 2010-02-22 2018-03-13 큐알엔에이, 인크. 피롤린-5-카르복실레이트 환원효소 1(pycr1)에 대한 천연 안티센스 전사체의 억제에 의한 pycr1과 관련된 질환의 치료
NZ601293A (en) 2010-02-23 2014-10-31 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor
WO2011105902A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 8-beta (c8-beta) and uses thereof
WO2011105901A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 9 (c9) and uses thereof
WO2011105900A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 8-alpha (c8-alpha) and uses thereof
CN102939385A (zh) 2010-02-24 2013-02-20 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
WO2011104128A2 (en) 2010-02-24 2011-09-01 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
EP2361927A1 (de) 2010-02-26 2011-08-31 BASF Plant Science Company GmbH Pflanzen mit verbesserten Ertragseigenschaften und Verfahren zu ihrer Herstellung
EP2361985A1 (de) 2010-02-26 2011-08-31 BASF Plant Science Company GmbH Pflanzen mit verbesserten Ertragseigenschaften und Verfahren zu ihrer Herstellung
BR112012022045A8 (pt) 2010-03-03 2018-06-19 Du Pont ''planta transgênica,semente transgênica,método para produzir uma planta transgênica,método para produzir sementes transgênicas,produto e/ou subproduto,polinucleotídeo isolado e planta ou semente''.
GB201003702D0 (en) 2010-03-05 2010-04-21 Univ Warwick Molecular engineering of a floral inducer for crop improvement
US8906875B2 (en) 2010-03-12 2014-12-09 The Brigham And Women's Hospital, Inc. Methods of treating vascular inflammatory disorders
WO2011113015A2 (en) 2010-03-12 2011-09-15 Avi Biopharma, Inc. Antisense modulation of nuclear hormone receptors
WO2011115818A1 (en) 2010-03-17 2011-09-22 Isis Pharmaceuticals, Inc. 5'-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
AU2011228707A1 (en) 2010-03-18 2012-09-27 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
EA201290930A1 (ru) 2010-03-18 2013-04-30 Басф Плант Сайенс Компани Гмбх Растения с улучшенными характеристиками урожайности и способ их получения
BR112012023503A2 (pt) 2010-03-19 2015-09-01 Basf Plant Science Co Gmbh Método para aumentar o rendimento em plantas em relação a plantas de controle, planta, construção, uso de uma construção, métodos para a produção de uma planta transgênica e de um produto, partes colhíveis de uma planta, produtos derivados de uma planta e uso de um ácido nucleico
EA201290936A1 (ru) 2010-03-19 2013-05-30 Басф Плант Сайенс Компани Гмбх Растения с улучшенными характеристиками урожайности и способ их получения
EP2371845A1 (de) 2010-03-22 2011-10-05 BASF Plant Science Company GmbH Installations dotées de caractéristiques de rendement améliorées et procédé de fabrication de celles-ci
CN102858979B (zh) 2010-04-09 2018-01-26 库尔纳公司 通过抑制成纤维细胞生长因子21(fgf21)的天然反义转录物而治疗fgf21相关疾病
EP2385129A1 (de) 2010-05-03 2011-11-09 BASF Plant Science Company GmbH Verbessertes Verfahren zur Genregulierung in Pflanzen
JP6066900B2 (ja) 2010-04-26 2017-01-25 エータイアー ファーマ, インコーポレイテッド システイニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
WO2011139799A2 (en) 2010-04-27 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
US8993738B2 (en) 2010-04-28 2015-03-31 Isis Pharmaceuticals, Inc. Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
CN103097524B (zh) 2010-04-28 2016-08-03 Atyr医药公司 与丙氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
US9127033B2 (en) 2010-04-28 2015-09-08 Isis Pharmaceuticals, Inc. 5′ modified nucleosides and oligomeric compounds prepared therefrom
RS56011B1 (sr) 2010-04-29 2017-09-29 Ionis Pharmaceuticals Inc Modulacija ekspresije transtiretina
US8986680B2 (en) 2010-04-29 2015-03-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
AU2011248457B2 (en) 2010-04-29 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
CN107090045A (zh) 2010-05-03 2017-08-25 霍夫曼-拉罗奇有限公司 用于肿瘤诊断和治疗的组合物和方法
JP6008841B2 (ja) 2010-05-03 2016-10-19 エータイアー ファーマ, インコーポレイテッド メチオニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CN105820252B (zh) 2010-05-03 2020-07-21 Atyr 医药公司 与苯丙氨酰-α-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
RU2693462C2 (ru) 2010-05-03 2019-07-03 Курна, Инк. Лечение заболеваний, связанных с сиртуином (sirt), путем ингибирования природного антисмыслового транскрипта к сиртуину (sirt)
AU2011248355B2 (en) 2010-05-03 2017-01-19 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Arginyl-tRNA synthetases
CN102985103A (zh) 2010-05-04 2013-03-20 Atyr医药公司 与p38多-tRNA合成酶复合物相关的治疗、诊断和抗体组合物的创新发现
DE112011101566T5 (de) 2010-05-04 2013-05-08 Basf Se Pflanzen mit erhöhter herbizidtoleranz
WO2011139431A1 (en) 2010-05-06 2011-11-10 Pioneer Hi-Bred International, Inc. Maize acc synthase 3 gene and protein and uses thereof
GB201007834D0 (en) 2010-05-11 2010-06-23 Vib Vzw Growth promoting fusion proteins
ES2705236T3 (es) 2010-05-12 2019-03-22 Univ Columbia Procedimientos para producir células enteroendocrinas que producen y secretan insulina
US9238042B2 (en) 2010-05-13 2016-01-19 Sarepta Therapeutics, Inc. Antisense modulation of interleukins 17 and 23 signaling
CN103200953B (zh) 2010-05-14 2017-02-15 Atyr 医药公司 与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
TWI531370B (zh) 2010-05-14 2016-05-01 可娜公司 藉由抑制par4天然反股轉錄本治療par4相關疾病
JP6027965B2 (ja) 2010-05-17 2016-11-16 エータイアー ファーマ, インコーポレイテッド ロイシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
NO2576783T3 (de) 2010-05-26 2018-04-28
JP6046607B2 (ja) 2010-05-27 2016-12-21 エータイアー ファーマ, インコーポレイテッド グルタミニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
WO2011156278A1 (en) 2010-06-07 2011-12-15 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
US8846637B2 (en) 2010-06-08 2014-09-30 Isis Pharmaceuticals, Inc. Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
WO2011161617A1 (en) 2010-06-24 2011-12-29 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
US20130139280A1 (en) 2010-06-25 2013-05-30 Jeong Sheop Shin Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
WO2012003207A2 (en) 2010-07-01 2012-01-05 E. I. Du Pont De Nemours And Company Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding pae and pae-like polypeptides
US20140137294A1 (en) 2010-07-08 2014-05-15 University Of Copenhagen Glucosinolate transporter protein and uses thereof
CA2804416C (en) 2010-07-12 2020-04-28 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
JP5998131B2 (ja) 2010-07-14 2016-09-28 カッパーアールエヌエー,インコーポレイテッド Discslargehomolog(dlg)dlg1への天然アンチセンス転写物の阻害によるdlg関連疾患の治療
EA201390111A1 (ru) 2010-07-16 2013-06-28 Басф Плант Сайенс Компани Гмбх Растения с улучшенными характеристиками урожайности и способ их получения
UA112969C2 (uk) 2010-08-03 2016-11-25 Сібас Юс Ллс Рослина, стійка до одного або більше ррх-інгібуючих гербіцидів, яка містить мутантний ген протопорфіриноген ix оксидази (ррх)
US20120122223A1 (en) 2010-08-03 2012-05-17 Cibus Us Llc Mutated protoporphyrinogen ix oxidase (ppx) genes
WO2012021794A1 (en) 2010-08-13 2012-02-16 Pioneer Hi-Bred International, Inc. Chimeric promoters and methods of use
EP2609205A4 (de) 2010-08-24 2014-03-26 Basf Plant Science Co Gmbh Pflanzen mit verbesserten ertragseigenschaften und verfahren zu ihrer herstellung
AU2011293294B2 (en) 2010-08-25 2016-03-24 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases
WO2012028673A1 (en) 2010-09-02 2012-03-08 Ludwig-Maximilians-Universitaet Muenchen Spontaneous organogenesis in plants
EP2426204A1 (de) 2010-09-02 2012-03-07 Ludwig-Maximilians-Universität München Spontane Knöllchenorganogenese in Pflanzen
US8481680B2 (en) 2010-10-05 2013-07-09 Genentech, Inc. Mutant smoothened and methods of using the same
ES2640755T3 (es) 2010-10-06 2017-11-06 Curna, Inc. Tratamiento de enfermedades relacionadas con la Sialidasa 4 (neu4) mediante inhibición del transcrito antisentido natural al gen neu4
EP2625292B1 (de) 2010-10-07 2018-12-05 The General Hospital Corporation Krebsbiomarker
CN103180445B (zh) 2010-10-22 2018-02-16 库尔纳公司 通过抑制α‑L‑艾杜糖醛酸酶(IDUA)的天然反义转录物而治疗IDUA相关疾病
CA2816056A1 (en) 2010-10-27 2012-05-03 Curna, Inc. Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1
CN103298943A (zh) 2010-11-10 2013-09-11 巴斯夫植物科学有限公司 产量相关性状增强的植物及其制备方法
AU2011325956B2 (en) 2010-11-12 2016-07-14 The General Hospital Corporation Polycomb-associated non-coding RNAs
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
CA3077910A1 (en) 2010-11-17 2012-05-24 Ionis Pharmaceuticals, Inc. Modulation of alpha synuclein expression
CA2818824A1 (en) 2010-11-23 2012-05-31 Joseph Collard Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog
US9834778B2 (en) 2010-12-06 2017-12-05 Basf Plant Science Company Gmbh Synthetic arcelin-5 promoter and methods of use thereof
CN103261424B (zh) 2010-12-16 2017-12-12 巴斯夫农业公司 对除草剂具有增强的耐受性的植物
EP2655657B1 (de) 2010-12-22 2018-12-05 Pioneer Hi-Bred International, Inc. Qtl im zusammenhang mit der und verfahren für die identifizierung der resistenz ganzer pflanzenfelder gegen sclerotinia
EP2663323B1 (de) 2011-01-14 2017-08-16 The General Hospital Corporation Verfahren zur anzielung von mir-128 zur regelung des cholesterin-/fettstoffwechsels
DE112012000525T5 (de) 2011-01-20 2013-10-24 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung
WO2012101599A2 (en) 2011-01-27 2012-08-02 Ramot At Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
EP2668200B1 (de) 2011-01-27 2017-03-15 Ramot at Tel-Aviv University Ltd. Inhibitoren vom lycogen-synthase-kinase-3
EP2670231A4 (de) 2011-02-01 2015-04-29 Colorado Wheat Res Foundation Inc Acetyl-coenzym-a-carboxylase-herbizidresistente pflanzen
DK2670404T3 (en) 2011-02-02 2018-11-19 Univ Princeton CIRCUIT MODULATORS AS VIRUS PRODUCTION MODULATORS
MX365647B (es) 2011-02-02 2019-06-10 Excaliard Pharmaceuticals Inc El uso de compuestos antisentido dirigidos al factor de crecimiento del tejido conectivo (ctgf) para tratar queloides o cicatrices hipertroficas.
US9273336B2 (en) 2011-02-21 2016-03-01 E. I. Du Pont De Nemours And Company Recombinant host cells having an increase in buoyant density
AR085394A1 (es) 2011-02-25 2013-09-25 Univ Nac De La Plata Unlp Proteasa de plantas
MX2013009749A (es) 2011-02-28 2013-10-01 Basf Plant Science Co Gmbh Plantas que tienen rasgos relacionados con rendimiento mejorado y metodos para producir los mismos.
MX2013009855A (es) 2011-02-28 2013-12-06 Basf Plant Science Co Gmbh Plantas que tienen rasgos relacionados con rendimiento mejorado y metodos para producir los mismos.
WO2012117368A1 (en) 2011-03-01 2012-09-07 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and producing methods thereof
MX359516B (es) 2011-04-12 2018-10-01 Moerae Matrix Inc Composiciones y metodos para prevenir o tratar enfermedades, afecciones, o procesos caracterizados por la proliferacion abrellante de fibro blasto y deposicion de matriz extracelular.
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
US9677084B2 (en) 2011-04-29 2017-06-13 Pioneer Hi-Bred International, Inc. Down-regulation of a homeodomain-leucine zipper I-class homeobox gene for improved plant performance
CA2834183A1 (en) 2011-05-19 2012-11-22 Enrique ROJO DE LA VIESCA Process for modifying the architecture and improving the yield of crop plants
CA2838588C (en) 2011-06-09 2021-09-14 Curna, Inc. Treatment of frataxin (fxn) related diseases by inhibition of natural antisense transcript to fxn
WO2012170347A1 (en) 2011-06-09 2012-12-13 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
EP2721160A2 (de) 2011-06-14 2014-04-23 Synthon Biopharmaceuticals B.V. Zusammensetzungen und verfahren zur herstellung und bioabdichtung auxotropher transgener pflanzen
WO2013009935A2 (en) 2011-07-12 2013-01-17 Two Blades Foundation Late blight resistance genes
WO2013012788A2 (en) 2011-07-15 2013-01-24 Syngenta Participations Ag Methods of increasing yield and stress tolerance in a plant
WO2013012643A1 (en) 2011-07-15 2013-01-24 Syngenta Participations Ag Polynucleotides encoding trehalose-6-phosphate phosphatase and methods of use thereof
WO2013017982A1 (en) 2011-08-01 2013-02-07 Basf Plant Science Company Gmbh Method for identification and isolation of terminator sequences causing enhanced transcription
EP3533873A1 (de) 2011-09-14 2019-09-04 Translate Bio MA, Inc. Multimere oligonukleotidverbindungen
WO2013040499A1 (en) 2011-09-14 2013-03-21 Northwestern University Nanoconjugates able to cross the blood-brain barrier
CN104011210B (zh) 2011-10-11 2018-05-01 布里格姆及妇女医院股份有限公司 神经退行性病症中的microRNA
US20150082480A1 (en) 2011-10-25 2015-03-19 Pioneer Hi Bred International Inc Methods to alter plant cell wall composition for improved biofuel production and silage digestibility
US20150159166A1 (en) 2011-10-31 2015-06-11 Pioneer Hi Bred International Inc Plant drought tolerance and nitrogen use efficiency by reducing plant sensitivity to ethylene
DK2790736T3 (en) 2011-12-12 2018-05-07 Oncoimmunin Inc In vivo delivery of oligonucleotides
EP2814951B1 (de) 2012-02-13 2019-04-03 Gamida-Cell Ltd. Kultivierung mesenchymaler stammzellen
WO2013134636A1 (en) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
CA2867385A1 (en) 2012-03-13 2013-09-19 Pioneer Hi-Bred International, Inc. Genetic reduction of male fertility in plants
WO2013138309A1 (en) 2012-03-13 2013-09-19 Pioneer Hi-Bred International, Inc. Genetic reduction of male fertility in plants
EP2825648B1 (de) 2012-03-15 2018-09-05 CuRNA, Inc. Behandlung von erkrankungen im zusammenhang mit dem brain-derived neurotrophen faktor (bdnf) mittels hemmung des natürlichen antisense-transkripts gegen bdnf
US9610362B2 (en) 2012-03-16 2017-04-04 Valerion Therapeutics, Llc Antisense conjugates for decreasing expression of DMPK
WO2013154799A1 (en) 2012-04-09 2013-10-17 Isis Pharmaceuticals, Inc. Tricyclic nucleosides and oligomeric compounds prepared therefrom
US9221864B2 (en) 2012-04-09 2015-12-29 Isis Pharmaceuticals, Inc. Tricyclic nucleic acid analogs
AU2013248981B2 (en) 2012-04-20 2018-11-29 Aptamir Therapeutics, Inc. Mirna modulators of thermogenesis
WO2013163628A2 (en) 2012-04-27 2013-10-31 Duke University Genetic correction of mutated genes
AU2013262649A1 (en) 2012-05-16 2015-01-22 Rana Therapeutics, Inc. Compositions and methods for modulating smn gene family expression
KR102028784B1 (ko) 2012-05-16 2019-10-04 트랜슬레이트 바이오 인코포레이티드 유전자 발현을 조절하기 위한 조성물 및 방법
US10045499B2 (en) 2012-05-24 2018-08-14 Iowa State University Research Foundation, Inc. Arabidopsis nonhost resistance gene(s) and use thereof to engineer disease resistant plants
WO2013184209A1 (en) 2012-06-04 2013-12-12 Ludwig Institute For Cancer Research Ltd. Mif for use in methods of treating subjects with a neurodegenerative disorder
AR091489A1 (es) 2012-06-19 2015-02-11 Basf Se Plantas que tienen una mayor tolerancia a herbicidas inhibidores de la protoporfirinogeno oxidasa (ppo)
EP2677035A1 (de) 2012-06-22 2013-12-25 BASF Plant Science Company GmbH Pflanzen mit verbesserten Ertragseigenschaften und Verfahren zu ihrer Herstellung
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US20150216892A1 (en) 2012-08-03 2015-08-06 Aptamir Therapeutics, Inc. Cell-specific delivery of mirna modulators for the treatment of obesity and related disorders
EP2885312A4 (de) 2012-08-15 2016-01-20 Isis Pharmaceuticals Inc Verfahren zur herstellung oligomerer verbindungen unter verwendung von modifizierten kappungsprotokollen
WO2014027021A1 (en) 2012-08-16 2014-02-20 Vib Vzw Means and methods for altering the lignin pathway in plants
WO2014037735A1 (en) 2012-09-10 2014-03-13 University Of Leicester Atsp1, an e3 ubiquitin ligase, and its use
US9029335B2 (en) 2012-10-16 2015-05-12 Isis Pharmaceuticals, Inc. Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
AU2013336237A1 (en) 2012-10-22 2015-06-11 Sabag-Rfa Ltd A system for delivering therapeutic agents into living cells and cells nuclei
US20150299718A1 (en) 2012-11-20 2015-10-22 Rajeev Gupta Engineering Plants for Efficient Uptake and Utilization of Urea to Improve
US20150351390A1 (en) 2012-12-21 2015-12-10 Pioneer Hi-Bred International, Inc. Compositions and methods for auxin-analog conjugation
EP2754715A1 (de) 2013-01-11 2014-07-16 Consejo Superior De Investigaciones Científicas (CSIC) Stresstolerante Pflanzen
WO2014117988A1 (en) 2013-01-29 2014-08-07 Basf Plant Science Company Gmbh Fungal resistant plants expressing hcp7
BR112015017345A2 (pt) 2013-01-29 2017-11-21 Basf Plant Science Co Gmbh método para aumentar a resistência aos fungos em uma planta, construção de vetor recombinante, planta transgênica, método para produção de planta transgência, uso de qualquer um dos ácidos nucleicos exógenos, parte que pode ser colhida de uma planta transgênica, produto derivado de uma planta, método para produção de um produto e método para cultivar uma planta resistente a fungos
CN104981149B (zh) 2013-01-29 2022-03-04 巴斯夫植物科学有限公司 表达ein2的抗真菌植物
WO2014121436A1 (en) 2013-02-05 2014-08-14 Plant Bioscience Limited Transgenic plants
CA2900005A1 (en) 2013-03-08 2014-09-12 Basf Plant Science Company Gmbh Fungal resistant plants expressing mybtf
WO2014164014A1 (en) 2013-03-11 2014-10-09 Pioneer Hi-Bred International, Inc. Genes for improving nutrient uptake and abiotic stress tolerance in plants
WO2014164466A1 (en) 2013-03-12 2014-10-09 E. I. Du Pont De Nemours And Company Methods for the identification of variant recognition sites for rare-cutting engineered double-strand-break-inducing agents and compositions and uses thereof
US9803214B2 (en) 2013-03-12 2017-10-31 Pioneer Hi-Bred International, Inc. Breeding pair of wheat plants comprising an MS45 promoter inverted repeat that confers male sterility and a construct that restores fertility
WO2014164074A1 (en) 2013-03-13 2014-10-09 Pioneer Hi-Bred International, Inc. Enhanced nitrate uptake and nitrate translocation by over-expressing maize functional low-affinity nitrate transporters in transgenic maize
WO2014164116A1 (en) 2013-03-13 2014-10-09 Pioneer Hi-Bred International, Inc. Functional expression of bacterial major facilitator superfamily (sfm) gene in maize to improve agronomic traits and grain yield
CA2903693A1 (en) 2013-03-14 2014-10-02 Pioneer Hi-Bred International, Inc. Maize stress related transcription factor 18 and uses thereof
US9790515B2 (en) 2013-03-14 2017-10-17 Cibus Us Llc Mutated allene oxide synthase 2 (AOS2) genes
US9957515B2 (en) 2013-03-15 2018-05-01 Cibus Us Llc Methods and compositions for targeted gene modification
KR102304487B1 (ko) 2013-03-15 2021-09-24 시버스 유에스 엘엘씨 올리고뉴클레오타이드 매개 유전자 보수를 사용한 표적화된 유전자 변형
KR102647792B1 (ko) 2013-03-15 2024-03-14 시버스 유에스 엘엘씨 올리고뉴클레오타이드 매개 유전자 보수를 사용한 표적화된 유전자 변형의 효율을 증가시키기 위한 방법 및 조성물
WO2014143996A2 (en) 2013-03-15 2014-09-18 Pioneer Hi-Bred International, Inc. Compositions and methods of use of acc oxidase polynucleotides and polypeptides
CA2903297A1 (en) 2013-03-15 2014-09-25 Pioneer Hi-Bred International, Inc. Modulation of acc deaminase expression
CA2904817C (en) 2013-03-21 2022-10-18 Vib Vzw Means and methods for the reduction of photorespiration in crops
CR20190269A (es) 2013-05-01 2019-09-13 Ionis Pharmaceuticals Inc COMPOSICIONES Y MÉTODOS PARA MODULAR LA EXPRESIÓN DE TTR Y VHB (Divisonal 2015-0612)
JP6869720B2 (ja) 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法
EP2816115A1 (de) 2013-06-17 2014-12-24 BASF Plant Science Company GmbH Pflanzen mit einem oder mehreren Merkmalen eines erhöhten Ertrages und Verfahren zu deren Herstellung
WO2014207743A2 (en) 2013-06-24 2014-12-31 Ramot At Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
CA2917103C (en) 2013-07-09 2021-01-12 Board Of Trustees Of Michigan State University Transgenic plants produced with a k-domain, and methods and expression cassettes related thereto
US11459579B2 (en) 2013-07-09 2022-10-04 Board Of Trustees Of Michigan State University Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto
US11162096B2 (en) 2013-10-14 2021-11-02 Ionis Pharmaceuticals, Inc Methods for modulating expression of C9ORF72 antisense transcript
CA2844640A1 (en) 2013-12-06 2015-06-06 The University Of British Columbia Method for treatment of castration-resistant prostate cancer
EP2896698A1 (de) 2014-01-17 2015-07-22 BASF Plant Science Company GmbH Pflanzen mit einer oder mehreren Merkmalen zum erhöhten Ertrag und Verfahren zu deren Herstellung
WO2015116680A1 (en) 2014-01-30 2015-08-06 Two Blades Foundation Plants with enhanced resistance to phytophthora
EP3812473A1 (de) 2014-01-31 2021-04-28 Temple University Of The Commonwealth System Of Higher Education Bag3 als ziel für die therapie von herzinsuffizienz
DK3102197T3 (en) 2014-02-04 2018-11-19 Genentech Inc Smoothened mutant and methods for its use
HUE065691T2 (hu) 2014-03-14 2024-06-28 Cibus Us Llc Eljárások és készítmények célzott génmódosítás hatékonyságának növelésére oligonukleotid-közvetített génjavítás alkalmazásával
WO2015142910A1 (en) 2014-03-17 2015-09-24 Isis Pharmaceuticals, Inc. Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom
US10006027B2 (en) 2014-03-19 2018-06-26 Ionis Pharmaceuticals, Inc. Methods for modulating Ataxin 2 expression
US10308934B2 (en) 2014-03-19 2019-06-04 Ionis Pharmaceuticals, Inc. Compositions for modulating Ataxin 2 expression
SG11201608109TA (en) 2014-04-01 2016-10-28 Ionis Pharmaceuticals Inc Compositions for modulating sod-1 expression
WO2015150465A2 (en) 2014-04-03 2015-10-08 Basf Se Plants having increased tolerance to herbicides
US10221416B2 (en) 2014-04-24 2019-03-05 Ionis Pharmaceuticals, Inc. Oligomeric compounds comprising alpha-beta-constrained nucleic acid
EP3608406B1 (de) 2014-05-01 2023-02-15 Ionis Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur modulation der expression vom komplementfaktor b
WO2015171603A1 (en) 2014-05-06 2015-11-12 Two Blades Foundation Methods for producing plants with enhanced resistance to oomycete pathogens
CN106535876B (zh) 2014-06-04 2020-09-11 埃克西奎雷股份有限公司 免疫调节剂通过脂质体球形核酸的多价递送以用于预防或治疗应用
WO2015190922A1 (en) 2014-06-10 2015-12-17 Erasmus University Medical Center Rotterdam Antisense oligonucleotides useful in treatment of pompe disease
WO2015200697A1 (en) 2014-06-25 2015-12-30 The General Hospital Corporation Targeting human satellite ii (hsatii)
US10487314B2 (en) 2014-06-26 2019-11-26 The Trustees Of Columbia University In The City Of New York Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
EP3166964A1 (de) 2014-07-08 2017-05-17 Vib Vzw Mittel und verfahren zur steigerung des pflanzenertrags
NZ728159A (en) 2014-07-14 2018-08-31 Univ Washington State Nanos2 knock-out that ablates germline cells
WO2016033424A1 (en) 2014-08-29 2016-03-03 Genzyme Corporation Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b
WO2016040748A1 (en) 2014-09-12 2016-03-17 Ionis Pharmaceuticals, Inc. Compositions and methods for detection of smn protein in a subject and treatment of a subject
WO2016049512A1 (en) 2014-09-26 2016-03-31 University Of Massachusetts Rna-modulating agents
EP3204501B1 (de) 2014-10-06 2019-01-09 Altria Client Services LLC Genetische kontrolle des achselknospenwachstums bei tabakpflanzen
JP2018501201A (ja) 2014-11-17 2018-01-18 モイライ マトリックス インコーポレイテッド 異常な線維芽細胞増殖および細胞外マトリックス沈着を特徴とする疾患、状態、またはプロセスを予防または処置するための組成物および方法
EP3220895B1 (de) 2014-11-21 2022-08-31 Northwestern University Sequenzspezifische zelluläre aufnahme von sphärischen nukleinsäurenanopartikelkonjugaten
WO2016100309A1 (en) 2014-12-16 2016-06-23 Pioneer Hi-Bred International, Inc. Restoration of male fertility in wheat
US9688707B2 (en) 2014-12-30 2017-06-27 Ionis Pharmaceuticals, Inc. Bicyclic morpholino compounds and oligomeric compounds prepared therefrom
WO2016112132A1 (en) 2015-01-06 2016-07-14 Ionis Pharmaceuticals, Inc. Compositions for modulating expression of c9orf72 antisense transcript
US10538763B2 (en) 2015-01-16 2020-01-21 Ionis Pharmaceuticals, Inc. Compounds and methods for modulation of DUX4
US10538782B2 (en) 2015-01-21 2020-01-21 Basf Se Plants having increased tolerance to herbicides
WO2016124918A1 (en) 2015-02-03 2016-08-11 The Institute Of Genetics And Developmental Biology Plants with increased seed size
US10485196B2 (en) 2015-02-03 2019-11-26 The Institute Of Genetics And Developmental Biology Chinese Academy Of Scinces Rice plants with altered seed phenotype and quality
BR112017016688B1 (pt) 2015-02-04 2024-01-23 Basf Plant Science Company Gmbh Método para aumentar a resistência fúngica, método para a produção de um produto e método para criar uma planta resistente a fungos
GB201501941D0 (en) 2015-02-05 2015-03-25 British American Tobacco Co Method
US10676726B2 (en) 2015-02-09 2020-06-09 Duke University Compositions and methods for epigenome editing
BR112017016789A2 (pt) 2015-02-11 2018-05-08 Basf Se métodos para produzir uma planta transgênica, para controlar a vegetação indesejada e para o cultivo da planta, molécula de ácido nucleico, construção de ácido nucleico, vetor, polipeptídeo hppd mutado, núcleo de célula vegetal, núcleo de célula vegetal transgênica, planta transgênica, uso do ácido nucleico, combinação útil, processo para a preparação de uma combinação útil e uso de uma combinação útil
GB201502409D0 (en) 2015-02-13 2015-04-01 British American Tobacco Co Method
US11129844B2 (en) 2015-03-03 2021-09-28 Ionis Pharmaceuticals, Inc. Compositions and methods for modulating MECP2 expression
CN107921082A (zh) 2015-03-12 2018-04-17 莫伊莱麦屈克斯公司 含有mk2抑制剂肽的组合物用于治疗非小细胞肺癌的用途
WO2016146633A1 (en) 2015-03-18 2016-09-22 Basf Se Recombinant microorganism for improved production of fine chemicals
EP3283502A4 (de) 2015-04-07 2019-04-03 The General Hospital Corporation Verfahren zur reaktivierung von genen auf dem inaktiven x-chromosom
WO2016167780A1 (en) 2015-04-16 2016-10-20 Ionis Pharmaceuticals, Inc. Compositions for modulating expression of c9orf72 antisense transcript
WO2016182881A1 (en) 2015-05-09 2016-11-17 Two Blades Foundation Late blight resistance gene from solanum americanum and methods of use
US10519474B2 (en) 2015-06-04 2019-12-31 Basf Se Recombinant microorganism for improved production of fine chemicals
MX2017016109A (es) 2015-06-12 2018-04-20 Basf Se Microorganismo recombinante para la produccion mejorada de productos quimicos finos.
EP3314250A4 (de) 2015-06-26 2018-12-05 Beth Israel Deaconess Medical Center, Inc. Auf tetraspanin 33 (tspann33) in myeloidabgeleiteten suppressorzellen abzielende krebstherapie
US10590425B2 (en) 2015-06-29 2020-03-17 Caris Science, Inc. Therapeutic oligonucleotides
CA2993652A1 (en) 2015-07-28 2017-02-02 Caris Science, Inc. Targeted oligonucleotides
EP3353303B1 (de) 2015-09-25 2023-08-02 Ionis Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur modulation von ataxin 3-expression
WO2017062790A1 (en) 2015-10-09 2017-04-13 Two Blades Foundation Cold shock protein receptors and methods of use
EP3362571A4 (de) 2015-10-13 2019-07-10 Duke University Genom-engineering mit typ-i-crispr-systemen in eukaryotischen zellen
CA3001979A1 (en) 2015-10-22 2017-04-27 Basf Se Plants having increased tolerance to herbicides
CA3007424A1 (en) 2015-11-05 2017-05-11 Children's Hospital Los Angeles "mobilizing leukemia cells"
AU2016355178B9 (en) 2015-11-19 2019-05-30 Massachusetts Institute Of Technology Lymphocyte antigen CD5-like (CD5L)-interleukin 12B (p40) heterodimers in immunity
WO2017096395A1 (en) 2015-12-04 2017-06-08 Ionis Pharmaceuticals, Inc. Methods of treating breast cancer
US10993995B2 (en) 2015-12-07 2021-05-04 Erasmus University Medical Center Rotterdam Enzymatic replacement therapy and antisense therapy for pompe disease
US10907160B2 (en) 2016-01-05 2021-02-02 Ionis Pharmaceuticals, Inc. Methods for reducing LRRK2 expression
AU2017213826A1 (en) 2016-02-04 2018-08-23 Curis, Inc. Mutant smoothened and methods of using the same
EA201891629A1 (ru) 2016-02-09 2019-03-29 Сибас Юс Ллс Способы и композиции для повышения эффективности нацеленной модификации генов с применением опосредуемой олигонуклеотидами репарации генов
US11234996B2 (en) 2016-02-25 2022-02-01 The Brigham And Women's Hospital, Inc. Treatment methods for fibrosis targeting SMOC2
US10731173B2 (en) 2016-03-11 2020-08-04 Altria Client Services Llc Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers
WO2017161168A1 (en) 2016-03-16 2017-09-21 Ionis Pharmaceuticals, Inc. Modulation of dyrk1b expression
CA3013799A1 (en) 2016-03-16 2017-09-21 Ionis Pharmaceuticals, Inc. Methods of modulating keap1
WO2017161357A1 (en) 2016-03-18 2017-09-21 Caris Science, Inc. Oligonucleotide probes and uses thereof
WO2017167623A1 (en) 2016-03-30 2017-10-05 Basf Se Fermentative production of n-butylacrylate using alcohol acyl transferase enzymes
US10563216B2 (en) 2016-04-18 2020-02-18 Bloomsburg University of Pennsylvania Compositions and methods of delivering molecules to plants
EP3868880A1 (de) 2016-04-29 2021-08-25 Basf Plant Science Company GmbH Verbesserte verfahren zur modifizierung von zielnukleinsäuren
EP3054014A3 (de) 2016-05-10 2016-11-23 BASF Plant Science Company GmbH Benutzung einer fungizids auf transgenen pflanzen
EP3458591A1 (de) 2016-05-20 2019-03-27 BASF Agro B.V. Dual-transit-peptide zum targeting von polypeptiden
CA3025047A1 (en) 2016-05-24 2017-11-30 Basf Se Method for controlling ppo resistant weeds
IL298701B2 (en) 2016-05-25 2024-03-01 Caris Science Inc Oligonucleotide probes and their uses
WO2017202715A1 (en) 2016-05-26 2017-11-30 Nunhems B.V. Seedless fruit producing plants
AU2017286811A1 (en) 2016-06-17 2018-11-22 Ionis Pharmaceuticals, Inc. Modulation of gys1 expression
WO2017223129A1 (en) 2016-06-22 2017-12-28 North Carolina State University Method for increasing nitrogen-use efficiency and or nitrogen-utilisation efficiency in plants
AU2017296195A1 (en) 2016-07-11 2019-01-24 Translate Bio Ma, Inc. Nucleic acid conjugates and uses thereof
JP7264805B2 (ja) 2016-07-15 2023-04-25 ビーエーエスエフ ソシエタス・ヨーロピア 除草剤耐性の増加した植物
CA3032014A1 (en) 2016-07-27 2018-02-01 BASF Agro B.V. Plants having increased tolerance to herbicides
CA3030354A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
WO2018019845A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
WO2018024695A1 (en) 2016-08-05 2018-02-08 Basf Se Method for controlling ppo resistant weeds
NL2017294B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Natural cryptic exon removal by pairs of antisense oligonucleotides.
NL2017295B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Antisense oligomeric compound for Pompe disease
US20210368793A1 (en) 2016-08-05 2021-12-02 Basf Se Method for Controlling PPO Resistant Weeds
EP3278667A1 (de) 2016-08-05 2018-02-07 Basf Se Verfahren zur kontrolle von ppo-inhibitor resistenten unkräutern
US11193136B2 (en) 2016-08-09 2021-12-07 Vib Vzw Cellulose synthase inhibitors and mutant plants
BR112019001862B1 (pt) 2016-08-09 2022-10-18 Basf Se Métodos para controlar o crescimento de ervas daninhas resistentes a ppo, e uso do composto de fórmula (i).1
EP3281525A1 (de) 2016-08-09 2018-02-14 Basf Se Verfahren zur bekämpfung von ppo-resistanten unkraut
US10905121B2 (en) 2016-08-09 2021-02-02 Basf Se Method for controlling PPO resistant weeds
EP3281524A1 (de) 2016-08-09 2018-02-14 Basf Se Verfahren zur bekämpfung von ppo-resistanten unkraut
WO2018029031A1 (en) 2016-08-09 2018-02-15 Basf Se Method for controlling ppo resistant weeds
EP3281523A1 (de) 2016-08-09 2018-02-14 Basf Se Verfahren zur bekämpfung von ppo-resistanten unkraut
CN109661233A (zh) 2016-10-06 2019-04-19 Ionis 制药公司 缀合低聚化合物的方法
WO2018067985A1 (en) 2016-10-07 2018-04-12 Altria Client Services Llc Composition and methods for producing tobacco plants and products having reduced tobacco-specific nitrosamines (tsnas)
WO2018081817A2 (en) 2016-10-31 2018-05-03 University Of Massachusetts Targeting microrna-101-3p in cancer therapy
JOP20190104A1 (ar) 2016-11-10 2019-05-07 Ionis Pharmaceuticals Inc مركبات وطرق لتقليل التعبير عن atxn3
WO2018102745A1 (en) 2016-12-02 2018-06-07 Cold Spring Harbor Laboratory Modulation of lnc05 expression
US11041166B2 (en) 2016-12-16 2021-06-22 Two Blades Foundation Late blight resistance genes and methods of use
WO2018114759A1 (en) 2016-12-20 2018-06-28 BASF Agro B.V. Plants having increased tolerance to herbicides
JP2020503066A (ja) 2016-12-27 2020-01-30 インバイオス エン.フェー. シアル酸付加化合物のin vivo合成
WO2018140214A1 (en) 2017-01-24 2018-08-02 Pioneer Hi-Bred International, Inc. Nematicidal protein from pseudomonas
CN110573623A (zh) 2017-02-09 2019-12-13 福建农林大学 用于提高植物产量的磷酸盐转运蛋白的表达
WO2018165564A1 (en) 2017-03-09 2018-09-13 Ionis Pharmaceuticals, Inc. Morpholino modified oligomeric compounds
US11767520B2 (en) 2017-04-20 2023-09-26 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
WO2018195486A1 (en) 2017-04-21 2018-10-25 The Broad Institute, Inc. Targeted delivery to beta cells
US11445692B2 (en) 2017-05-15 2022-09-20 Equi-Nom Ltd. Quantitative trait loci (QTL) associated with shatter resistant capsules in sesame and uses thereof
EP3658675A1 (de) 2017-07-28 2020-06-03 Two Blades Foundation Potyvirusresistenzgene und verfahren zur verwendung
US11197884B2 (en) 2017-08-18 2021-12-14 Ionis Pharmaceuticals, Inc. Modulation of the notch signaling pathway for treatment of respiratory disorders
WO2019051173A1 (en) 2017-09-08 2019-03-14 Ionis Pharmaceuticals, Inc. MODULATORS OF SMAD7 EXPRESSION
US11104912B2 (en) 2017-09-11 2021-08-31 Altria Client Services Llc Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers
WO2019055460A1 (en) 2017-09-13 2019-03-21 The Children's Medical Center Corporation COMPOSITIONS AND METHODS FOR THE TREATMENT OF TRANSPOSON-ASSOCIATED DISEASES
TWI809004B (zh) 2017-11-09 2023-07-21 美商Ionis製藥公司 用於降低snca表現之化合物及方法
WO2019108619A1 (en) 2017-11-28 2019-06-06 Two Blades Foundation Methods and compositions for enhancing the disease resistance of plants
AU2018376915B2 (en) 2017-11-29 2024-08-01 Basf Se Plants having increased tolerance to herbicides
CN111788306A (zh) 2017-12-20 2020-10-16 巴斯夫欧洲公司 核酸酶以及用于制备和使用其的方法
WO2019126641A2 (en) 2017-12-21 2019-06-27 Ionis Pharmaceuticals, Inc. Modulation of frataxin expression
US11034969B2 (en) 2017-12-22 2021-06-15 Altria Client Services Llc Plant comprising recombinant polynucleotides encoding a pigment regulatory transcription factor with a tissue-preferred promoter
CN107868123B (zh) 2017-12-25 2020-05-12 中国农业科学院作物科学研究所 一种同时提高植物产量和抗性的基因及其应用
AU2019207703A1 (en) 2018-01-09 2020-07-16 Cibus Europe B.V. Shatterproof genes and mutations
CN111954464A (zh) 2018-01-12 2020-11-17 双刃基金会 秆锈病抗性基因及使用方法
TW201934129A (zh) 2018-01-15 2019-09-01 美商Ionis製藥公司 Dnm2表現之調節劑
WO2019142099A1 (en) 2018-01-17 2019-07-25 Basf Se Plants having increased tolerance to herbicides
CN111818794A (zh) 2018-02-14 2020-10-23 中国科学院遗传与发育生物学研究所 增加营养物利用效率的方法
TWI840345B (zh) 2018-03-02 2024-05-01 美商Ionis製藥公司 Irf4表現之調節劑
EP3759127A4 (de) 2018-03-02 2022-03-30 Ionis Pharmaceuticals, Inc. Verbindungen und verfahren zur modulation des amyloid-beta-vorläuferproteins
WO2019183440A1 (en) 2018-03-22 2019-09-26 Ionis Pharmaceuticals, Inc. Methods for modulating fmr1 expression
US12049631B2 (en) 2018-03-30 2024-07-30 Rheinische Friedrich-Wilhelms-Universitat Bonn Aptamers for targeted activation of T cell-mediated immunity
EP3773017B1 (de) 2018-04-03 2022-06-08 Altria Client Services LLC Zusammensetzungen und verfahren zur herstellung von tabakpflanzen und -produkten mit erhöhtem phenylalanin und verringerten tabakspezifischen nitrosaminen (tsnas)
KR20200141470A (ko) 2018-04-06 2020-12-18 칠드런'즈 메디컬 센터 코포레이션 체세포 재프로그래밍 및 각인의 조정을 위한 조성물 및 방법
MX2020010721A (es) 2018-04-11 2020-11-06 Ionis Pharmaceuticals Inc Moduladores de la expresion de ezh2.
US11732250B2 (en) 2018-04-26 2023-08-22 Basf Se Lipase enzymes
WO2019211143A1 (en) 2018-05-03 2019-11-07 Basf Se Amylase enzymes
BR112020020957B1 (pt) 2018-05-09 2022-05-10 Ionis Pharmaceuticals, Inc Compostos oligoméricos, população e composição farmacêutica dos mesmos e seus usos
CN112189053B (zh) 2018-05-09 2024-05-14 Ionis制药公司 用于减少atxn3表达的化合物和方法
WO2019219933A1 (en) 2018-05-17 2019-11-21 Vib Vzw An engineered combinatorial module of transcription factors to boost production of monoterpenoid indole alkaloids
AU2019287635A1 (en) 2018-06-14 2020-12-17 Ionis Pharmaceuticals, Inc. Compounds and methods for increasing STMN2 expression
WO2019238832A1 (en) 2018-06-15 2019-12-19 Nunhems B.V. Seedless watermelon plants comprising modifications in an abc transporter gene
TWI833770B (zh) 2018-06-27 2024-03-01 美商Ionis製藥公司 用於減少 lrrk2 表現之化合物及方法
WO2020010059A1 (en) 2018-07-02 2020-01-09 Aptamir Therapeutics, Inc. Targeted delivery of therapeutic agents to human adipocytes
AU2019310097A1 (en) 2018-07-25 2021-02-04 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing ATXN2 expression
EP3843845A4 (de) 2018-08-29 2022-05-11 University Of Massachusetts Hemmung von proteinkinasen zur behandlung von friedreich-ataxie
EP3847263A1 (de) 2018-09-07 2021-07-14 Basf Plant Science Company GmbH Verbessertes verfahren zur herstellung von hohen pufa-spiegeln in pflanzen
CA3110651A1 (en) 2018-09-07 2020-03-12 Basf Plant Science Company Gmbh Improved method for the production of high levels of pufa in plants
CA3110664A1 (en) 2018-09-07 2020-03-12 Basf Plant Science Company Gmbh Improved method for the production of high levels of pufa in plants
US20210340518A1 (en) 2018-10-18 2021-11-04 Basf Se Method for the production of acrylic acid or salts thereof
TW202028222A (zh) 2018-11-14 2020-08-01 美商Ionis製藥公司 Foxp3表現之調節劑
WO2020102630A1 (en) 2018-11-15 2020-05-22 Ionis Pharmaceuticals, Inc. Modulators of irf5 expression
CA3124395A1 (en) 2018-12-20 2020-06-25 Basf Plant Science Company Gmbh Native delivery of biomolecules into plant cells using ionic complexes with cell-penetrating peptides
WO2020152104A2 (en) 2019-01-22 2020-07-30 Basf Se Method for production of 4-cyano benzoic acid or salts thereof
CN113660857A (zh) 2019-01-24 2021-11-16 奥驰亚客户服务有限公司 包含降低的烟碱和降低的烟草特异性亚硝胺的烟草植物
WO2020160453A1 (en) 2019-01-31 2020-08-06 Ionis Pharmaceuticals, Inc. Modulators of yap1 expression
GB201902253D0 (en) 2019-02-19 2019-04-03 Univ Court Univ Of Glasgow Methods for optogenetic manipulation of stomatal function
WO2020171889A1 (en) 2019-02-19 2020-08-27 University Of Rochester Blocking lipid accumulation or inflammation in thyroid eye disease
JP7492526B2 (ja) 2019-02-27 2024-05-29 アイオーニス ファーマシューティカルズ, インコーポレーテッド Malat1発現のモジュレーター
US20220186200A1 (en) 2019-03-11 2022-06-16 Basf Se Amylases and methods for making and using them
CA3133614A1 (en) 2019-03-14 2020-09-17 Rothamsted Research Limited Genetically modified plants with enhanced drought tolerance
WO2020193535A2 (en) 2019-03-25 2020-10-01 Basf Se Amylase enzymes
US20220170001A1 (en) 2019-03-25 2022-06-02 Basf Se Amylase Enzymes
WO2020193532A1 (en) 2019-03-25 2020-10-01 Basf Se Cleaning composition having amylase enzymes
CN113728104B (zh) 2019-03-29 2023-10-27 Ionis制药公司 用于调节ube3a-ats的化合物和方法
WO2020229241A1 (en) 2019-05-10 2020-11-19 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
CN114450405A (zh) 2019-06-27 2022-05-06 双刃基金会 工程化atrlp23模式识别受体及使用方法
KR20220029579A (ko) 2019-06-27 2022-03-08 바스프 플랜트 사이언스 컴퍼니 게엠베하 진균 포자의 형질전환 방법
US20210071193A1 (en) 2019-07-12 2021-03-11 The Regents Of The University Of California Plants with enhanced resistance to bacterial pathogens
US11786546B2 (en) 2019-07-26 2023-10-17 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating GFAP
KR20220062517A (ko) 2019-08-15 2022-05-17 아이오니스 파마수티컬즈, 인코포레이티드 결합 변형된 올리고머 화합물 및 이의 용도
EP4017974A1 (de) 2019-08-22 2022-06-29 Basf Se Amylasevarianten
BR112022004545A2 (pt) 2019-09-12 2022-05-31 Basf Se Métodos para aumentar a expressão derivada de um promotor vegetal e produzir uma planta, construção de expressão recombinante, vetor de expressão, célula ou planta transgênica, cultura de células transgênicas e usos
WO2021058691A1 (en) 2019-09-26 2021-04-01 Basf Se Method for the production of beta-alanine or salts thereof
WO2021069387A1 (en) 2019-10-07 2021-04-15 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
EP4069852A1 (de) 2019-12-03 2022-10-12 Basf Se Regulatorische nukleinsäuremoleküle zur steigerung der genexpression bei pflanzen
CN114846144A (zh) 2019-12-16 2022-08-02 巴斯夫农业种子解决方案美国有限责任公司 将dna或突变精确引入小麦基因组
WO2021121921A1 (en) 2019-12-16 2021-06-24 BASF Agricultural Solutions Seed US LLC Codon-optimized cas9 endonuclease encoding polynucleotide
WO2021122080A1 (en) 2019-12-16 2021-06-24 BASF Agricultural Solutions Seed US LLC Improved genome editing using paired nickases
TW202140787A (zh) 2020-02-28 2021-11-01 美商Ionis製藥公司 用於調節smn2之化合物及方法
KR20220149567A (ko) 2020-03-04 2022-11-08 바스프 에스이 이. 콜라이 및 바실루스에서의 발현을 위한 셔틀 벡터
US20230212593A1 (en) 2020-03-04 2023-07-06 Basf Se Method for the production of constitutive bacterial promoters conferring low to medium expression
MX2022013707A (es) 2020-05-01 2022-12-07 Ionis Pharmaceuticals Inc Compuestos y metodos para modular atxn1.
CN115605589A (zh) 2020-05-15 2023-01-13 巴斯夫欧洲公司(De) 改进的用于生产类异戊二烯的方法
CN116096899A (zh) 2020-06-29 2023-05-09 Ionis制药公司 调节plp1的化合物和方法
US11730133B2 (en) 2020-10-21 2023-08-22 Equi-Nom Ltd High yield sesame
AU2021381363A1 (en) 2020-11-18 2023-06-15 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating angiotensinogen expression
CA3205040A1 (en) 2020-12-18 2022-06-23 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating factor xii
WO2022240931A1 (en) 2021-05-11 2022-11-17 Two Blades Foundation Methods for preparing a library of plant disease resistance genes for functional testing for disease resistance
TW202317765A (zh) 2021-06-18 2023-05-01 美商Ionis製藥公司 用於降低ifnar1表現的化合物及方法
AU2022324708A1 (en) 2021-08-06 2024-02-15 Kws Vegetables B.V. Durable downy mildew resistance in spinach
CA3230261A1 (en) 2021-09-03 2023-03-09 Manuel Dubald Plants having increased tolerance to herbicides
US11395470B1 (en) 2021-09-14 2022-07-26 Equi-Nom Ltd. Sesame with high oil content and/or high yield
WO2023043220A1 (ko) 2021-09-16 2023-03-23 주식회사 큐마인 Wfdc2의 발현을 조절하는 안티센스 화합물
EP4408859A1 (de) 2021-09-30 2024-08-07 Two Blades Foundation Pflanzenkrankheitsresistenzgene gegen stammrost und verfahren zur verwendung
WO2023067192A1 (en) 2021-10-21 2023-04-27 Consejo Superior De Investigaciones Cientificas (Csic) Methods for improving abiotic stress resistance
WO2023105244A1 (en) 2021-12-10 2023-06-15 Pig Improvement Company Uk Limited Editing tmprss2/4 for disease resistance in livestock
AU2022422286A1 (en) 2021-12-22 2024-07-04 BASF Agricultural Solutions Seed US LLC Improved screening method for genome edited events
WO2023131616A1 (en) 2022-01-05 2023-07-13 Vib Vzw Means and methods to increase abiotic stress tolerance in plants
WO2023131637A1 (en) 2022-01-06 2023-07-13 Vib Vzw Improved silage grasses
WO2023144199A1 (en) 2022-01-26 2023-08-03 Vib Vzw Plants having reduced levels of bitter taste metabolites
WO2024026474A1 (en) 2022-07-29 2024-02-01 Regeneron Pharmaceuticals, Inc. Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
WO2024044352A1 (en) 2022-08-26 2024-02-29 The General Hospital Corporation Methods and compositions for prognosis and treatment of dilated cardiomyopathy and heart failure
WO2024083579A1 (en) 2022-10-20 2024-04-25 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
WO2024089011A1 (en) 2022-10-26 2024-05-02 BASF Agricultural Solutions Seed US LLC Excision of recombinant dna from the genome of plant cells
WO2024094678A2 (en) 2022-11-02 2024-05-10 Basf Se Improved method for the production of natural vanillin
US20240182561A1 (en) 2022-11-04 2024-06-06 Regeneron Pharmaceuticals, Inc. Calcium voltage-gated channel auxiliary subunit gamma 1 (cacng1) binding proteins and cacng1-mediated delivery to skeletal muscle
WO2024107765A2 (en) 2022-11-14 2024-05-23 Regeneron Pharmaceuticals, Inc. Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
WO2024126113A1 (en) 2022-12-12 2024-06-20 BASF Agricultural Solutions Seed US LLC Plants having increased tolerance to herbicides
WO2024132947A1 (en) 2022-12-19 2024-06-27 Basf Se New cellulase promoters for fungal protein production
WO2024156593A1 (en) 2023-01-27 2024-08-02 Basf Se New genomic integration site for fungal protein and fine chemicals production

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503151A (en) * 1980-12-10 1985-03-05 Research Corporation Recombinant cDNA construction method and hybrid nucleotides useful in cloning
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4882279A (en) * 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
DE3788914T2 (de) * 1986-09-08 1994-08-25 Ajinomoto Kk Verbindungen zur Spaltung von RNS an eine spezifische Position, Oligomere, verwendet bei der Herstellung dieser Verbindungen und Ausgangsprodukte für die Synthese dieser Oligomere.
US4950599A (en) * 1987-01-29 1990-08-21 Wolf Bertling Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments
WO1990014092A1 (en) * 1989-05-18 1990-11-29 Cell Genesys, Inc. Single-strand site-directed modification of mammalian genes in vivo
EP0626012B1 (de) * 1992-02-11 2003-07-09 Cell Genesys, Inc. Erzielen von homozygotem durch zielgerichtete genetische ereignisse
JPH07506252A (ja) * 1992-04-24 1995-07-13 エス・アール・アイ・インターナシヨナル 真核細胞内でのイン・ビボ相同配列ターゲッティング
EP0656747A4 (de) * 1992-08-21 1997-05-07 Univ California Zusammensetzung und verfahren zur änderung von dns-sequenzen durch homologe rekombination.
CN1124980A (zh) * 1993-03-31 1996-06-19 海布里顿公司 具有改良抗流感活性的经修饰寡核苷酸

Also Published As

Publication number Publication date
US5565350A (en) 1996-10-15
US5756325A (en) 1998-05-26
JPH09506511A (ja) 1997-06-30
KR100386337B1 (ko) 2004-03-24
PT733059E (pt) 2001-03-30
AU1399595A (en) 1995-06-27
DE69425903T2 (de) 2001-02-15
EP0733059A4 (de) 1997-05-21
CN1215755A (zh) 1999-05-05
US5871984A (en) 1999-02-16
KR960706500A (ko) 1996-12-09
CN1142829A (zh) 1997-02-12
DE733059T1 (de) 1997-08-28
JP3585238B2 (ja) 2004-11-04
CN1048254C (zh) 2000-01-12
EP0733059A1 (de) 1996-09-25
ATE196311T1 (de) 2000-09-15
DE69425903D1 (de) 2000-10-19
GR3034988T3 (en) 2001-03-30
CN1117866C (zh) 2003-08-13
ES2149962T3 (es) 2000-11-16
NZ278490A (en) 1998-03-25
AU691550B2 (en) 1998-05-21
CA2178729A1 (en) 1995-06-15
WO1995015972A1 (en) 1995-06-15
EP0733059B1 (de) 2000-09-13

Similar Documents

Publication Publication Date Title
DK0733059T3 (da) Forbindelser og fremgangsmåder til site-rettede mutationer i eukaryote celler
NZ509163A (en) Burnable coil holder
IL96768A (en) Site-specific recombination of dna in plant cells
NZ243500A (en) Nucleic acid encoding dihydrokaempferol hydroxylating enzyme (dhk) and its use in producing transgenic flowering plants
ATE213019T1 (de) Chimäre oligomere mit einer rns- spaltungsaktivität
ATE209286T1 (de) Vorrichtung zum verbinden von armierten betonteilen
WO2000032814A3 (en) Methods for producing selected interstrand cross-links in nucleic acids and applications thereof
EP0196879A3 (de) Verfahren zur Erzeugung von unbehaarten Schweinen
JPS5439315A (en) Method of manufacturing high-tensile steel-wire
JPS6462544A (en) Method of reinforcing and clamping construction of rc structure
FR2720076B1 (fr) Vecteurs navettes pour l'introduction d'ADN dans des mycobactéries et utilisation de ces bactéries comme vaccins.
Park et al. Transcriptional Regulation of the Cell Proliferation-Related Genes by 20-OH Ecdysone and Ursolic acid in Drosophila
JPS5389815A (en) Steel bar for low temperature
NO165318C (no) Fremgangsmaate ved sammenskjoeting av lederne i to elektriske kabler, og skjoet fremstilt ifoelge fremgangsmaaten.
Ding et al. Artificial intelligence static control model in converter steelmaking
Scott R & D: BASF invests in process engineering
ES477358A1 (es) Perfeccionamientos en las guarniciones terminales para cin- tas de elevadores de cargas y banda de amarre.
Llory et al. A turning point in human factors studies
Multer THE ROLE OF ANCHOR LABELING IN MAGNITUDE ESTIMATION AND CATEGORY ESTIMATION.
Furukawa Steel's Drawability Improved
Kurten Turnover in Pleistocene faunas.
MD537C2 (ro) Procedeu de protecţie a plantelor contra secetei
ZW7885A1 (en) N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
Housego French Steelmakers to Merge
Singh DC Eaf technology